
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Antioxidants: powering the fight against fetal hypoxia - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5330858AF252D3053085001A4A9954.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="transb">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368550/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Philosophical Transactions of the Royal Society B: Biological Sciences">
<meta name="citation_title" content="Antioxidants: powering the fight against fetal hypoxia">
<meta name="citation_author" content="Kimberley J Botting-Lawford">
<meta name="citation_author_institution" content="EGA Institute for Women’s Health, University College London, London, UK">
<meta name="citation_author" content="Katie L Skeffington">
<meta name="citation_author_institution" content="Translational Health Sciences, University of Bristol, Bristol, UK">
<meta name="citation_author" content="Michael P Murphy">
<meta name="citation_author_institution" content="MRC-Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK">
<meta name="citation_author" content="Anna L David">
<meta name="citation_author_institution" content="EGA Institute for Women’s Health, University College London, London, UK">
<meta name="citation_author" content="Dino A Giussani">
<meta name="citation_author_institution" content="Department of Physiology, Development and Neuroscience (PDN), University of Cambridge, Cambridge, UK">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="380">
<meta name="citation_issue" content="1933">
<meta name="citation_firstpage" content="20240183">
<meta name="citation_doi" content="10.1098/rstb.2024.0183">
<meta name="citation_pmid" content="40836816">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368550/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368550/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368550/pdf/rstb.2024.0183.pdf">
<meta name="description" content="Hypoxia is a common challenge in fetal development. Short-term acute episodes occur during labour owing to uterine contractions or umbilical cord compression. In response, the fetus prioritizes oxygen and nutrient delivery to the brain, heart and ...">
<meta name="og:title" content="Antioxidants: powering the fight against fetal hypoxia">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Hypoxia is a common challenge in fetal development. Short-term acute episodes occur during labour owing to uterine contractions or umbilical cord compression. In response, the fetus prioritizes oxygen and nutrient delivery to the brain, heart and ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368550/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12368550">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1098/rstb.2024.0183"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/rstb.2024.0183.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12368550%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12368550/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12368550/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368550/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-transb.gif" alt="Philosophical Transactions of the Royal Society B: Biological Sciences logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Philosophical Transactions of the Royal Society B: Biological Sciences" title="Link to Philosophical Transactions of the Royal Society B: Biological Sciences" shape="default" href="http://rstb.royalsocietypublishing.org/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Philos Trans R Soc Lond B Biol Sci</button></div>. 2025 Aug 21;380(1933):20240183. doi: <a href="https://doi.org/10.1098/rstb.2024.0183" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1098/rstb.2024.0183</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Philos%20Trans%20R%20Soc%20Lond%20B%20Biol%20Sci%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Philos%20Trans%20R%20Soc%20Lond%20B%20Biol%20Sci%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Philos%20Trans%20R%20Soc%20Lond%20B%20Biol%20Sci%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Philos%20Trans%20R%20Soc%20Lond%20B%20Biol%20Sci%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Antioxidants: powering the fight against fetal hypoxia</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Botting-Lawford%20KJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Kimberley J Botting-Lawford</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Kimberley J Botting-Lawford</span></h3>
<div class="p">
<sup><sup>1</sup></sup>EGA Institute for Women’s Health, University College London, London, UK</div>
<div>Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review and editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Botting-Lawford%20KJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Kimberley J Botting-Lawford</span></a>
</div>
</div>
<sup>1,</sup><sup>†,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Skeffington%20KL%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Katie L Skeffington</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Katie L Skeffington</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Translational Health Sciences, University of Bristol, Bristol, UK</div>
<div>Writing – original draft, Writing – review and editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Skeffington%20KL%22%5BAuthor%5D" class="usa-link"><span class="name western">Katie L Skeffington</span></a>
</div>
</div>
<sup>2,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Murphy%20MP%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Michael P Murphy</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Michael P Murphy</span></h3>
<div class="p">
<sup><sup>3</sup></sup>MRC-Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK</div>
<div>Writing – original draft, Writing – review and editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Murphy%20MP%22%5BAuthor%5D" class="usa-link"><span class="name western">Michael P Murphy</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22David%20AL%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Anna L David</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Anna L David</span></h3>
<div class="p">
<sup><sup>1</sup></sup>EGA Institute for Women’s Health, University College London, London, UK</div>
<div>Conceptualization, Writing – original draft, Writing – review and editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22David%20AL%22%5BAuthor%5D" class="usa-link"><span class="name western">Anna L David</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Giussani%20DA%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Dino A Giussani</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Dino A Giussani</span></h3>
<div class="p">
<sup><sup>4</sup></sup>Department of Physiology, Development and Neuroscience (PDN), University of Cambridge, Cambridge, UK</div>
<div>Conceptualization, Funding acquisition, Writing – original draft, Writing – review and editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Giussani%20DA%22%5BAuthor%5D" class="usa-link"><span class="name western">Dino A Giussani</span></a>
</div>
</div>
<sup>4,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup><sup>1</sup></sup>EGA Institute for Women’s Health, University College London, London, UK</div>
<div id="aff2">
<sup><sup>2</sup></sup>Translational Health Sciences, University of Bristol, Bristol, UK</div>
<div id="aff3">
<sup><sup>3</sup></sup>MRC-Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK</div>
<div id="aff4">
<sup><sup>4</sup></sup>Department of Physiology, Development and Neuroscience (PDN), University of Cambridge, Cambridge, UK</div>
<div class="author-notes p">
<div class="fn" id="first-authorship1">
<sup>
<sup>†</sup>
</sup><p class="display-inline">Kimberley J. Botting-Lawford and Katie L. Skeffington are joint first authors.</p>
</div>
<div class="fn" id="fn2"><p>One contribution of 17 to a discussion meeting issue ‘Pregnancy at high altitude: the challenge of hypoxia’.</p></div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Kimberley J Botting-Lawford</span></strong>: <span class="role">Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review and editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Katie L Skeffington</span></strong>: <span class="role">Writing – original draft, Writing – review and editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Michael P Murphy</span></strong>: <span class="role">Writing – original draft, Writing – review and editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Anna L David</span></strong>: <span class="role">Conceptualization, Writing – original draft, Writing – review and editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Dino A Giussani</span></strong>: <span class="role">Conceptualization, Funding acquisition, Writing – original draft, Writing – review and editing</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 29; Revised 2025 Jun 6; Accepted 2025 Jun 9; Collection date 2025 Aug 21.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Authors.</div>
<p>Published by the Royal Society under the terms of the Creative Commons Attribution License <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>, which permits unrestricted use, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12368550  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40836816/" class="usa-link">40836816</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Hypoxia is a common challenge in fetal development. Short-term acute episodes occur during labour owing to uterine contractions or umbilical cord compression. In response, the fetus prioritizes oxygen and nutrient delivery to the brain, heart and adrenal glands at the expense of other organs, a mechanism known as the fetal brain-sparing response. However, prolonged fetal hypoxia can occur in many conditions, including placental insufficiency, pre-eclampsia, high-altitude pregnancy and fetal congenital heart disease. Chronic hypoxia increases placental and fetal oxidative stress, triggering increased long-term cardiovascular risks in adult offspring, including hypertension and coronary artery disease. Antioxidants could potentially prevent this. However, as reactive oxygen species play a crucial role in the fetal brain-sparing response, excessive antioxidant use could weaken fetal defences against acute hypoxia, increasing the risk of hypoxic–ischaemic encephalopathy. Thus, for clinical use, an antioxidant should protect against programmed cardiovascular disease while preserving fetal brain sparing. This review summarizes preclinical evidence on the efficacy of antioxidants in preventing cardiovascular disease in the offspring of hypoxic pregnancy. We compare their effects on fetal brain sparing, highlighting the ability of the mitochondria-targeted antioxidant MitoQ to protect against programmed cardiovascular disease while preserving fetal brain sparing and outlining steps for clinical translation.</p>
<p>This article is part of the discussion meeting issue ‘Pregnancy at high altitude: the challenge of hypoxia’.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> hypoxia, high altitude, fetal growth restriction, antioxidant, MitoQ, clinical translation, pregnancy</p></section></section><section id="s1"><h2 class="pmc_sec_title">1.  Introduction</h2>
<p>During embryonic and fetal development, oxygen plays a crucial role in cellular growth, differentiation and organogenesis. Inadequate oxygen supply to the fetus can lead to compensatory mechanisms, such as increased erythropoiesis, angiogenesis and changes in autonomic nervous system function, all of which can have long-term consequences on cardiovascular health [<a href="#B1" class="usa-link" aria-describedby="B1">1</a>–<a href="#B3" class="usa-link" aria-describedby="B3">3</a>]. Hypoxia also affects the development of key cardiovascular structures, including the heart and vasculature. Studies have demonstrated that chronic hypoxia can lead to left ventricular hypertrophy, reduced cardiomyocyte endowment and endothelial dysfunction [<a href="#B4" class="usa-link" aria-describedby="B4">4</a>–<a href="#B9" class="usa-link" aria-describedby="B9">9</a>]. Additionally, epigenetic modifications, such as DNA methylation and histone acetylation, play a significant role in fetal programming [<a href="#B10" class="usa-link" aria-describedby="B10">10</a>–<a href="#B12" class="usa-link" aria-describedby="B12">12</a>]. These modifications can lead to persistent changes in gene expression related to cardiovascular function, further increasing disease susceptibility [<a href="#B13" class="usa-link" aria-describedby="B13">13</a>].</p></section><section id="s2"><h2 class="pmc_sec_title">2.  Role of oxidative stress in hypoxia-induced cardiovascular disease</h2>
<p>A major contributor to the detrimental effects of hypoxia <em>in utero</em> is oxidative stress, which arises when there is an imbalance between reactive oxygen species (ROS) production and antioxidant defences. During hypoxia, ROS are generated by multiple processes, a major source being the mitochondria, where impaired oxygen availability leads to electron leakage and superoxide formation. Additional sources include upregulated NADPH oxidases (e.g. NOX2 and NOX4), uncoupled nitric oxide synthase, xanthine oxidase activity and endoplasmic reticulum stress (reviewed in [<a href="#B14" class="usa-link" aria-describedby="B14">14</a>]). Under normal physiological conditions, ROS play an important role in cellular signalling and homeostasis, for example, contributing to processes involved in immunity, cell differentiation and autophagy (reviewed in [<a href="#B15" class="usa-link" aria-describedby="B15">15</a>,<a href="#B16" class="usa-link" aria-describedby="B16">16</a>]). Under hypoxic conditions, an increase in ROS is also involved in mounting an appropriate physiological response—for example, via regulation of hypoxic inducible factor 1α (HIF-1α), which is an important sensor of cellular oxygen levels. In normoxia, prolyl-hydrolase enzymes target HIF-1α for degradation, however, in hypoxia, an increase in superoxide radicals inhibits prolyl hydrolase, allowing HIF-1α to activate appropriate metabolic changes such as erythropoiesis [<a href="#B17" class="usa-link" aria-describedby="B17">17</a>,<a href="#B18" class="usa-link" aria-describedby="B18">18</a>].</p>
<p>Under chronically hypoxic conditions, however, ROS production can become excessive, leading to detrimental effects, including oxidative damage of lipids, proteins and DNA. Oxidative stress also disrupts nitric oxide (NO) signalling, a crucial regulator of vascular tone. Reduced NO bioavailability leads to impaired vasodilatation, contributing to endothelial dysfunction and vascular remodelling, programming hypertension and atherosclerosis later in life [<a href="#B13" class="usa-link" aria-describedby="B13">13</a>,<a href="#B19" class="usa-link" aria-describedby="B19">19</a>,<a href="#B20" class="usa-link" aria-describedby="B20">20</a>]. Additionally, oxidative stress can activate inflammation, increasing the expression of pro-inflammatory cytokines and adhesion molecules, which further exacerbates endothelial damage, cardiovascular remodelling and dysfunction [<a href="#B21" class="usa-link" aria-describedby="B21">21</a>]. Reducing excessive oxidative stress through the use of antioxidants is being investigated as a potential therapy during pregnancies compromised by chronic fetal hypoxia to improve maternal and neonatal/offspring outcomes. However, ROS also play important physiological roles during normal pregnancy, crucially in the fetal defence against acute episodes of hypoxia through the fetal brain-sparing response.</p></section><section id="s3"><h2 class="pmc_sec_title">3.  The fetal cardiovascular response to acute hypoxia: the fetal brain-sparing response</h2>
<p>The physiology mediating the fetal cardiovascular response to acute hypoxia is well characterized and involves activation of the autonomic nervous system, the release of endocrine vasoconstrictors and local redox responses at the level of the vasculature [<a href="#B22" class="usa-link" aria-describedby="B22">22</a>]. Activation of the autonomic nervous system is triggered by the carotid chemoreflex, which induces bradycardia (slow heart rate) through the vagus nerve and activates the sympathetic chain to modulate perfusion. Arterioles regulate blood flow by either decreasing (vasoconstriction) or dilating (vasodilatation) their luminal diameter, depending on physiological demand. During fetal hypoxia, activation of the sympathetic nervous system leads to peripheral vasoconstriction, which can be measured by a fall in femoral arterial blood flow [<a href="#B23" class="usa-link" aria-describedby="B23">23</a>]. By contrast, hypoxia affects cerebral arterioles directly, relaxing their smooth muscle, decreasing vascular resistance and increasing perfusion to meet metabolic demands [<a href="#B24" class="usa-link" aria-describedby="B24">24</a>]. Dilatation of the cerebral vascular bed during acute hypoxia in the fetus can be measured by an increase in fetal carotid blood flow [<a href="#B23" class="usa-link" aria-describedby="B23">23</a>]. It is the net effect of this differential vasomotion in the fetal circulation that allows a greater proportion of fetal cardiac output to be directed to the fetal brain, what is known as the fetal brain-sparing response [<a href="#B22" class="usa-link" aria-describedby="B22">22</a>].</p>
<p>Once triggered by a carotid chemoreflex, the peripheral vasoconstriction is maintained by the release of constrictor hormones into the fetal circulation, including catecholamines, vasopressin, neuropeptide Y and angiotensin II [<a href="#B22" class="usa-link" aria-describedby="B22">22</a>]. Furthermore, local vascular redox responses, shaped by the interaction between NO and ROS, such as the superoxide anion (O₂<sup>•</sup>⁻), serve as a key regulator of peripheral vasoconstriction. While NO promotes vasodilation through the relaxation of the smooth muscle in the wall of arteries, O₂<sup>•</sup>⁻ limits NO bioavailability by sequestering it to form the peroxynitrite molecule (ONOO⁻), which then degrades to products that react with endogenous thiol systems [<a href="#B25" class="usa-link" aria-describedby="B25">25</a>]. During acute hypoxia, both NO and O₂<sup>•</sup>⁻ formation are increased, but hypoxia favours an increased O₂<sup>•</sup>⁻ : NO ratio, thereby contributing to the fetal peripheral vasoconstriction [<a href="#B22" class="usa-link" aria-describedby="B22">22</a>]. Increased NO synthesis in the fetal circulation during hypoxia has been confirmed through using L-NAME, an inhibitor of NO synthase, which enhances the fetal femoral vasoconstrictor response to acute hypoxia [<a href="#B26" class="usa-link" aria-describedby="B26">26</a>]. Increased O₂<sup>•</sup>⁻ synthesis in the fetal circulation during hypoxia has been confirmed through the use of antioxidants [<a href="#B22" class="usa-link" aria-describedby="B22">22</a>,<a href="#B27" class="usa-link" aria-describedby="B27">27</a>]. Fetal treatment with antioxidants during acute hypoxia quenches the increased O₂<sup>•</sup>⁻ production, enhancing NO bioavailability, which weakens the fetal femoral vasoconstrictor response to acute hypoxia by opposing the chemoreflex and endocrine vasoconstrictor drive [<a href="#B22" class="usa-link" aria-describedby="B22">22</a>,<a href="#B27" class="usa-link" aria-describedby="B27">27</a>]. Thus, ROS are not simply by-products of hypoxia but play an active physiological role in regulating blood flow during hypoxic stress. Consequently, there are concerns surrounding the use of antioxidants to treat fetal hypoxia to protect against the programming of cardiovascular disease, as they may reduce O₂<sup>•</sup>⁻ in the fetal vasculature and, consequently, diminish peripheral vasoconstriction and thereby the fetal brain-sparing response.</p></section><section id="s4"><h2 class="pmc_sec_title">4.  Antioxidants and the modulation of the fetal brain-sparing response</h2>
<p>The importance of ROS in the regulation of peripheral vasoconstriction and the fetal brain-sparing response to acute hypoxia was first identified by the Giussani and colleagues laboratory. In these experiments, fetal sheep were exposed to acute hypoxia with and without the antioxidant vitamin C [<a href="#B27" class="usa-link" aria-describedby="B27">27</a>]. These fetuses were previously surgically instrumented with catheters and flow probes that enabled the recording of heart rate, blood pressure, blood flow and vascular resistance in the femoral artery following full post-surgical recovery. By modulating the NO to O₂<sup>•</sup>⁻ ratio in favour of NO, Thakor <em>et al</em>. [<a href="#B27" class="usa-link" aria-describedby="B27">27</a>] demonstrated that vitamin C blunted the hypoxia-induced peripheral vasoconstriction (<a href="#T1" class="usa-link">table 1</a>; <a href="#F1" class="usa-link">figure 1</a>) without affecting bradycardia. These results demonstrated that while O₂<sup>•</sup>⁻ was not required to sense hypoxia or trigger the fall in fetal heart rate, it was an essential component of the fetal peripheral vasoconstriction. Subsequently, other antioxidants and modulators of NO availability, such as melatonin [<a href="#B31" class="usa-link" aria-describedby="B31">31</a>], allopurinol [<a href="#B28" class="usa-link" aria-describedby="B28">28</a>] and pravastatin [<a href="#B53" class="usa-link" aria-describedby="B53">53</a>], have all been shown to blunt the femoral vasoconstriction when fetuses are exposed to acute hypoxia (<a href="#T1" class="usa-link">table 1</a>; <a href="#F1" class="usa-link">figure 1</a>). Importantly, blocking NO restores the magnitude of the fetal peripheral vasoconstriction in response to hypoxia in the presence of antioxidants [<a href="#B27" class="usa-link" aria-describedby="B27">27</a>,<a href="#B28" class="usa-link" aria-describedby="B28">28</a>,<a href="#B31" class="usa-link" aria-describedby="B31">31</a>,<a href="#B53" class="usa-link" aria-describedby="B53">53</a>]. This confirms that it is the balance between the dilator effects of NO and the constrictor effects of O₂<sup>•</sup>⁻ that acts as a vascular oxidant tone, contributing to the peripheral vasoconstriction during hypoxia and, thereby, the fetal brain-sparing response. Therefore, caution is advised when using conventional antioxidants to protect the hypoxic fetus against programmed cardiovascular disease in adulthood as a result of oxidative stress. This is because their use may weaken the fetal brain-sparing response to acute hypoxia, of the type that may occur during labour and delivery, placing the fetal brain at risk of injury and hypoxic–ischaemic encephalopathy. The ideal antioxidant would combat hypoxia-induced oxidative stress while preserving the fetal brain-sparing response. Therefore, the research effort has focused on the mitochondria-targeted antioxidant MitoQ.</p>
<section class="tw xbox font-sm" id="T1"><h3 class="obj_head">Table 1. </h3>
<div class="caption p"><p>Effect of antioxidants on the fetal brain-sparing response to acute hypoxia and on long-term cardiovascular outcomes in offspring of hypoxic or healthy pregnancy.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="left" valign="bottom" rowspan="1" colspan="1">
<p>antioxidant</p>
</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">
<p>mechanism</p>
</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">
<p>effect on fetal brain-sparing response to acute hypoxia</p>
</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">
<p>effect of antioxidant treatment on cardiac and peripheral vascular dysfunction in the fetal or adult offspring following chronic fetal hypoxia</p>
</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">
<p>effect of antioxidant treatment on cardiac and peripheral vascular function following healthy control pregnancy</p>
</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>allopurinol</strong>
</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>inhibits xanthine oxidase, an enzyme responsible for producing ROS during oxidative stress. By limiting ROS production, allopurinol reduces oxidative damage</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>impaired</strong>
</p>
<p>impaired vasoconstriction of peripheral circulation in the late gestation sheep fetus [<a href="#B28" class="usa-link" aria-describedby="B28">28</a>]</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>protective</strong>
</p>
<p>improved cardiac contractility, sympathetic activity and recovery from an ischaemic challenge in the adult rat offspring [<a href="#B29" class="usa-link" aria-describedby="B29">29</a>].</p>
<p>Improved peripheral vasodilatation in the adolescent lamb [<a href="#B30" class="usa-link" aria-describedby="B30">30</a>]</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>no change in cardiac function in adult rat offspring of normoxic pregnancy [<a href="#B29" class="usa-link" aria-describedby="B29">29</a>].</p>
<p>Impaired dilatation of peripheral arteries compared with untreated controls at four months of age, but resolved by 15 months of age in adult rat offspring of normoxic pregnancy [<a href="#B30" class="usa-link" aria-describedby="B30">30</a>]</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>melatonin</strong>
</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>strong antioxidant and anti-inflammatory properties. It scavenges ROS and supports mitochondrial function, which is crucial in maintaining cellular energy and reducing oxidative damage during hypoxia</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>impaired</strong>
</p>
<p>impaired vasoconstriction of peripheral circulation in the late gestation sheep fetus [<a href="#B31" class="usa-link" aria-describedby="B31">31</a>]</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>protective</strong>
</p>
<p>decreased blood pressure in the newborn lamb [<a href="#B32" class="usa-link" aria-describedby="B32">32</a>].</p>
<p>Improved cardiac function and endothelial- dependent vasodilatation in the late-incubation hypoxic chicken embryo [<a href="#B33" class="usa-link" aria-describedby="B33">33</a>].</p>
<p>Improved cardiac structure and vascular function in adult rat offspring of hypoxic pregnancy [<a href="#B34" class="usa-link" aria-describedby="B34">34</a>]</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>change in cardiac structure [<a href="#B35" class="usa-link" aria-describedby="B35">35</a>], but no change in peripheral vascular function in adult rat offspring of normoxic pregnancy [<a href="#B33" class="usa-link" aria-describedby="B33">33</a>,<a href="#B34" class="usa-link" aria-describedby="B34">34</a>]</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>MitoQ</strong>
</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>a mitochondria-targeted antioxidant that specifically reduces ROS within mitochondria, protecting cells from oxidative stress and mitochondrial dysfunction during cellular hypoxia</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>protected</strong>
</p>
<p>only influences mitochondrial ROS : NO balance.</p>
<p>Does not affect oxidant tone in peripheral arteries.</p>
<p>Maintains the brain-sparing response in the late-gestation sheep fetus [<a href="#B36" class="usa-link" aria-describedby="B36">36</a>]</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>protective</strong>
</p>
<p>improved cardiac and vascular dysfunction programmed by hypoxic pregnancy in adult rats and in adolescent sheep [<a href="#B36" class="usa-link" aria-describedby="B36">36</a>,<a href="#B37" class="usa-link" aria-describedby="B37">37</a>]</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>normotensive, but enhanced dilatation of peripheral arteries to NO donor, sodium nitroprusside (SNP), in adolescent lambs born from normoxic pregnancy [<a href="#B36" class="usa-link" aria-describedby="B36">36</a>] and greater change in systolic blood pressure and peripheral blood flow to vasoconstrictor, phenylephrine in adult rat offspring of normoxic pregnancy [<a href="#B37" class="usa-link" aria-describedby="B37">37</a>]</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>nMitoQ</strong>
</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>nanoparticle-encapsulated MitoQ that does not cross the placenta</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>not known</strong>
</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>protective</strong>
</p>
<p>improved cardiac diastolic and mitochondrial function in adult female offspring of hypoxic pregnancy in rats [<a href="#B38" class="usa-link" aria-describedby="B38">38</a>,<a href="#B39" class="usa-link" aria-describedby="B39">39</a>].</p>
<p>Improved tolerance to cardiac ischaemia/reperfusion in adult offspring of hypoxic pregnancy in rats [<a href="#B40" class="usa-link" aria-describedby="B40">40</a>,<a href="#B41" class="usa-link" aria-describedby="B41">41</a>].</p>
<p>Improved vascular function in adult offspring of hypoxic pregnancy in rats [<a href="#B38" class="usa-link" aria-describedby="B38">38</a>,<a href="#B42" class="usa-link" aria-describedby="B42">42</a>]</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>altered cardiac diastolic function and enhanced sensitivity to vasodilator, methacholine at 13 months of age in adult rat offspring of normoxic pregnancy [<a href="#B38" class="usa-link" aria-describedby="B38">38</a>].</p>
<p>Males—reduced sensitivity to vasoconstrictor phenylephrine at four months, but enhanced sensitivity at 13 months of age in adult rat offspring of normoxic pregnancy [<a href="#B38" class="usa-link" aria-describedby="B38">38</a>].</p>
<p>Males—increased cardiac mitochondrial coupling efficiency in adult rat offspring of normoxic pregnancy [<a href="#B39" class="usa-link" aria-describedby="B39">39</a>].</p>
<p>No change on cardiac tolerance to ischaemia/reperfusion in adult rat offspring of normoxic pregnancy [<a href="#B41" class="usa-link" aria-describedby="B41">41</a>]</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p><strong><em>N</em>-acetylcysteine (NAC</strong>)</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>acts as a precursor to glutathione, one of the body’s most important endogenous antioxidants. NAC helps reduce oxidative stress by replenishing glutathione levels, scavenging free radicals and modulating redox balance</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>not known</strong>
</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>protective</strong>
</p>
<p>improved endothelial function in the late incubation hypoxic chicken embryo [<a href="#B43" class="usa-link" aria-describedby="B43">43</a>] and late gestation guinea-pig fetus [<a href="#B44" class="usa-link" aria-describedby="B44">44</a>], but postnatal cardiovascular function not known</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>not known</strong>
</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>phosphodiesterase inhibitors</strong>
</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>sildenafil and tadalafil promote vascular dilatation through inhibiting phosphodiesterase−5 (PDE5), increasing Cyclic guanosine monophosphate (cGMP) and enhancing NO signalling. They can also act as an antioxidant by inhibiting NADPH oxidase activity and enhancing endogenous antioxidant enzyme activity</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>impaired</strong>
</p>
<p>effect on fetal peripheral vasoconstrictor response to acute hypoxia is not known; however, sildenafil impaired the cardiovascular adaptation to chronic hypoxia in late gestation growth-restricted fetal sheep [<a href="#B45" class="usa-link" aria-describedby="B45">45</a>]</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>undefined</strong>
</p>
<p>
<em>sildenafil</em>
</p>
<p>improved vasodilatation in the late incubation hypoxic chicken embryos [<a href="#B46" class="usa-link" aria-describedby="B46">46</a>], but impaired vasodilation in growth-restricted fetal sheep [<a href="#B47" class="usa-link" aria-describedby="B47">47</a>].</p>
<p>Decreased fetal blood pressure and increased femoral blood flow in growth-restricted fetal sheep [<a href="#B45" class="usa-link" aria-describedby="B45">45</a>].</p>
<p>Postnatal cardiovascular function not known</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<em>sildenafil</em>
</p>
<p>impaired vasodilation in late gestation fetal sheep from control pregnancy [<a href="#B47" class="usa-link" aria-describedby="B47">47</a>].</p>
<p>increased occurrence of pulmonary hypertension in human neonates from mothers who received sildenafil in the STRIDER trial [<a href="#B48" class="usa-link" aria-describedby="B48">48</a>]</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>polyphenols</strong>
</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>resveratrol is a natural polyphenol with antioxidant properties. It also increases NO bioavailability through activation of sirtuin-1, which promotes NO production through endothelial NO synthase</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>not known</strong>
</p>
<p>maternal resveratrol treatment does not alter basal fetal haemodynamics [<a href="#B49" class="usa-link" aria-describedby="B49">49</a>]</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>protective</strong>
</p>
<p>protection against fetal demise, however, postnatal cardiovascular function is not known in a rat model of hypoxic pregnancy [<a href="#B50" class="usa-link" aria-describedby="B50">50</a>].</p>
<p>Improved cardiac recovery from an ischaemia/reperfusion if administered postnatally in a rat model of hypoxic pregnancy. High-fat diet [<a href="#B51" class="usa-link" aria-describedby="B51">51</a>]</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>not known</strong>
</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p><strong>pyrroloquinoline quinone (PQQ</strong>)</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>PQQ is a redox cofactor that sequesters mitochondrial O₂<sup>•</sup>⁻ and other free radicals</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>not known</strong>
</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>protective</strong>
</p>
<p>improved fetal cardiomyocyte endowment in spontaneously growth-restricted guinea pigs [<a href="#B52" class="usa-link" aria-describedby="B52">52</a>]</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>not known</strong>
</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>statins</strong>
</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>lowers cholesterol, but also has antioxidant properties by inhibiting NADPH oxidase, a key producer of ROS. This reduction in oxidative stress improves endothelial function and vascular reactivity</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>impaired</strong>
</p>
<p>impaired vasoconstriction of peripheral circulation in the late gestation sheep fetus [<a href="#B53" class="usa-link" aria-describedby="B53">53</a>]</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>protective</strong>
</p>
<p>enhanced NO bioavailability in the mouse term fetus [<a href="#B54" class="usa-link" aria-describedby="B54">54</a>,<a href="#B55" class="usa-link" aria-describedby="B55">55</a>]</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>not known</strong>
</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>vitamin C</strong>
</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>vitamin C is a potent antioxidant that neutralizes ROS and helps maintain endothelial function by enhancing the bioavailability of NO</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>impaired</strong>
</p>
<p>impaired vasoconstriction of peripheral circulation in the late gestation sheep fetus [<a href="#B27" class="usa-link" aria-describedby="B27">27</a>]</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>
<strong>protective</strong>
</p>
<p>improved postnatal endothelial function, blood pressure and cardiac function in the adult rat offspring of hypoxic pregnancy [<a href="#B6" class="usa-link" aria-describedby="B6">6</a>,<a href="#B56" class="usa-link" aria-describedby="B56">56</a>–<a href="#B58" class="usa-link" aria-describedby="B58">58</a>]</p>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>no change in postnatal cardiac function in adult rat and sheep offspring of normoxic pregnancy [<a href="#B6" class="usa-link" aria-describedby="B6">6</a>]. However, impaired peripheral vasodilation in adult rat and sheep offspring of normoxic pregnancy [<a href="#B6" class="usa-link" aria-describedby="B6">6</a>,<a href="#B58" class="usa-link" aria-describedby="B58">58</a>].</p>
<p>Reduced [<a href="#B56" class="usa-link" aria-describedby="B56">56</a>] or no change in postnatal blood pressure in adult rat and sheep offspring of normoxic pregnancy [<a href="#B58" class="usa-link" aria-describedby="B58">58</a>]</p>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><figure class="fig xbox font-sm" id="F1" title="Femoral vasoconstrictor response to acute hypoxia in late gestation fetal sheep."><h3 class="obj_head">Figure 1. </h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a32/12368550/4ca409af1541/rstb.2024.0183.f001.jpg" loading="lazy" height="1574" width="544" alt="Femoral vasoconstrictor response to acute hypoxia in late gestation fetal sheep."></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Femoral vasoconstrictor response to acute hypoxia in late gestation fetal sheep. Acute hypoxia in the late gestation sheep fetus results in an increase in femoral vascular resistance. Treating with MitoQ does not alter the hypoxia-induced femoral vasoconstrictor response; however, treatment with vitamin C (VitC), melatonin, allopurinol or pravastatin reduces it, weakening the fetal brain-sparing response to acute hypoxia. All fetuses were exposed to a 30 min acute hypoxia challenge (grey box) with either vehicle (open circles; appropriate for each antioxidant) or antioxidant exposure (coloured circles) the subsequent day. Green, MitoQ (MS010, 6 mg kg<sup>−1</sup>, <em>n</em> = 6; vehicle, 0.9% saline, <em>n</em> = 6; maternal IV); orange, vitamin C (0.94 ± 0.04 g kg<sup>−1</sup>, <em>n</em> = 8; vehicle, heparinized saline, <em>n</em> = 8, fetal IV); red, melatonin ([<a href="#B59" class="usa-link" aria-describedby="B59">59</a>] ± 9 mg kg<sup>−1</sup>, <em>n</em> = 6; vehicle, 0.5% ethanol in heparinized saline, <em>n</em> = 6, fetal IV); purple, allopurinol (150 mg kg<sup>−1</sup>, <em>n</em> = 6; vehicle, 4 M NaOH to achieve the same pH of the allopurinol solution, <em>n</em> = 6, maternal IV); blue, pravastatin (25 mg, <em>n</em> = 8; vehicle, 0.9% saline, <em>n</em> = 8, fetal IV). As this set of experiments was run over a decade, each animal’s vasoconstrictor response is reported as a percentage of its maximum femoral vasoconstriction during hypoxia when treated with a vehicle. Values are means ± s.e.m. averaged over 30 min epochs during normoxia and recovery and over 15 min epochs during acute hypoxia. Data were analysed by two-way repeated measures ANOVA for the effect of antioxidants over time. Significant (<em>p</em> &lt; 0.05) differences are: *versus vehicle. Reproduced with permission from [<a href="#B27" class="usa-link" aria-describedby="B27">27</a>,<a href="#B28" class="usa-link" aria-describedby="B28">28</a>,<a href="#B31" class="usa-link" aria-describedby="B31">31</a>,<a href="#B36" class="usa-link" aria-describedby="B36">36</a>,<a href="#B53" class="usa-link" aria-describedby="B53">53</a>].</p></figcaption></figure></section><section id="s5"><h2 class="pmc_sec_title">5.  Mitochondria-targeted antioxidant therapy with MitoQ</h2>
<p>MitoQ is comprised of a triphenylphosphonium ion, covalently bound to an antioxidant ubiquinol moiety (<a href="#F2" class="usa-link">figure 2</a>). The cation is positively charged, but it is lipophilic owing to the dissipation of the positive charge across the surface of the phenyl groups. Therefore, MitoQ can diffuse across any lipid bilayer and is not dependent on the expression of any carrier protein. The uptake of MitoQ into mitochondria is driven by the negative mitochondrial membrane potential and leads to mitochondrial MitoQ accumulation between 100- and 1000-fold greater than achieved by non-targeted antioxidants [<a href="#B60" class="usa-link" aria-describedby="B60">60</a>,<a href="#B61" class="usa-link" aria-describedby="B61">61</a>]. Once MitoQ is accumulated within the mitochondria, the long alkyl chain sits within the hydrophobic membrane, giving the antioxidant moiety access to the lipid bilayer [<a href="#B60" class="usa-link" aria-describedby="B60">60</a>]. Within the mitochondria, MitoQ is reduced by complex II to its active ubiquinol form, which acts as a chain-breaking antioxidant, blocking H<sub>2</sub>O<sub>2</sub>-induced lipid peroxidation and apoptosis without directly regulating H<sub>2</sub>O<sub>2</sub> production [<a href="#B62" class="usa-link" aria-describedby="B62">62</a>,<a href="#B63" class="usa-link" aria-describedby="B63">63</a>].</p>
<figure class="fig xbox font-sm" id="F2" title="The mechanism of action of MitoQ."><h3 class="obj_head">Figure 2. </h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12368550_rstb.2024.0183.f002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a32/12368550/209ee7725204/rstb.2024.0183.f002.jpg" loading="lazy" height="477" width="751" alt="The mechanism of action of MitoQ."></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The mechanism of action of MitoQ. MitoQ (top left) accumulates in the mitochondrial matrix owing to the mitochondrial membrane potential. MitoQ embeds in the inner mitochondrial membrane, with the phosphonium ion bound at the level of the fatty acid carbonyls and the quinone moiety inserted in the hydrophobic core of the phospholipid bilayer. Under hypoxic conditions, the generation of the superoxide anion (O₂<sup>•</sup>⁻) by the electron transport chain increases. O₂<sup>•</sup>⁻ is converted into H<sub>2</sub>O<sub>2</sub> by (manganese superoxide dismutase (MnSOD), which results in lipid peroxidation and mitochondrial damage. However, the presence of MitoQ is protective against lipid peroxidation without reacting directly with the O₂<sup>•</sup>⁻. This means that the reaction of O₂<sup>•</sup>⁻ with nitric oxide (NO) to form peroxynitrite remains unaffected. This is important because the interaction between O₂<sup>•</sup>⁻ and NO generates a local redox constrictor effect that contributes to the fetal peripheral vasoconstriction and, thereby, the fetal brain-sparing response to acute hypoxia. Therefore, MitoQ is the only known antioxidant that maintains the fetal brain-sparing response to acute hypoxia while preventing the developmental programming of cardiovascular disease in adult offspring of hypoxic pregnancy. Created in <a href="https://BioRender.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://BioRender.com</a>.</p></figcaption></figure><p>Hypoxia-induced lipid peroxidation results from a chain of events starting with an increase in hypoxia-induced mitochondrial O₂<sup>•</sup>⁻ release [<a href="#B64" class="usa-link" aria-describedby="B64">64</a>]. Some of the increased O₂<sup>•</sup>⁻ generated will react with circulating NO, potentiating peripheral vasoconstriction and contributing to the fetal brain-sparing response to acute hypoxia. The remaining O₂<sup>•</sup>⁻ will be converted to hydrogen peroxide within the mitochondria by manganese superoxide dismutase (MnSOD). The hydrogen peroxide then goes on to cause lipid peroxidation, especially in the mitochondrial inner membrane, where the unsaturated fatty acids are particularly susceptible to reacting with ROS to initiate lipid peroxidation [<a href="#B65" class="usa-link" aria-describedby="B65">65</a>]. MitoQ does not prevent the production of O₂<sup>•</sup>⁻ or directly interact with it to any large extent, but rather acts downstream in the chain of events by preventing lipid peroxidation and the resultant mitochondrial damage [<a href="#B66" class="usa-link" aria-describedby="B66">66</a>,<a href="#B67" class="usa-link" aria-describedby="B67">67</a>]. Therefore, O₂<sup>•</sup>⁻ remains available to bind NO in the peripheral circulation and maintain the fetal brain-sparing response (<a href="#F2" class="usa-link">figure 2</a>). Hence, MitoQ is the only antioxidant studied to date that protects against cardiovascular disease in the adult offspring programmed by fetal hypoxia without interfering with the fetal brain-sparing response to acute hypoxia [<a href="#B36" class="usa-link" aria-describedby="B36">36</a>].</p></section><section id="s6"><h2 class="pmc_sec_title">6.  Antioxidant therapy for programmed cardiovascular disease by developmental hypoxia</h2>
<section id="s6-1"><h3 class="pmc_sec_title">(a). Vitamin C</h3>
<p>Administration of vitamin C to the drinking water of rats undergoing hypoxic pregnancy (13% oxygen) decreased markers of fetal and placental oxidative stress and improved the cardiovascular health of the offspring in early adulthood at four months of age. Protective effects of vitamin C treatment during hypoxic pregnancy in the adult offspring included improved endothelial function, prevention of cardiac sympathetic dominance and restoration of baroreflex gain [<a href="#B6" class="usa-link" aria-describedby="B6">6</a>,<a href="#B56" class="usa-link" aria-describedby="B56">56</a>,<a href="#B57" class="usa-link" aria-describedby="B57">57</a>]. Furthermore, studies using an ovine model of improved human translational potential similarly demonstrated a protective effect of maternal intravenous treatment with vitamin C during hypoxic pregnancy on the cardiovascular health of lambs at nine months of age, including prevention of programmed systemic hypertension [<a href="#B58" class="usa-link" aria-describedby="B58">58</a>]. However, the concentration of vitamin C needed to prevent the interaction between O₂<sup>•</sup>⁻ and NO was unfortunately very high [<a href="#B68" class="usa-link" aria-describedby="B68">68</a>] and could promote adverse side effects, including oxaluria and kidney stones [<a href="#B69" class="usa-link" aria-describedby="B69">69</a>]. Second, clinical trials investigating the use of a lower dose of vitamin C in women at high risk of pre-eclampsia found no improvement in the incidence of pre-eclampsia, but there was a significant increase in the number of babies born with low birthweight [<a href="#B59" class="usa-link" aria-describedby="B59">59</a>,<a href="#B70" class="usa-link" aria-describedby="B70">70</a>]. Finally, vitamin C treatment also abolishes the important fetal brain-sparing response to hypoxia [<a href="#B27" class="usa-link" aria-describedby="B27">27</a>]. Therefore, although initial studies with vitamin C as a choice of antioxidant therapy provided proof of principle for the effectiveness of antioxidant treatment in protecting the adult offspring against cardiovascular disease programmed by hypoxic pregnancy, vitamin C is unfortunately not feasible for translation into clinical practice.</p></section><section id="s6-2"><h3 class="pmc_sec_title">(b). Melatonin</h3>
<p>Melatonin is another antioxidant that can cross the placenta [<a href="#B71" class="usa-link" aria-describedby="B71">71</a>], and its administration by intravenous or oral routes has shown an ability to increase fetal growth, improve placental function and protect against cardiovascular dysfunction in fetal and adult offspring of pregnancy compromised by undernutrition or glucocorticoid exposure [<a href="#B72" class="usa-link" aria-describedby="B72">72</a>–<a href="#B77" class="usa-link" aria-describedby="B77">77</a>]. In the hypoxic chicken embryo, melatonin administered topically onto the chorioallantoic membrane improves cardiac contractility and endothelial function, demonstrating that it can exert protective effects through direct actions on the fetus, not just via protection against oxidative stress of the mother and/or placenta [<a href="#B33" class="usa-link" aria-describedby="B33">33</a>]. A recent study in rats investigated whether maternal oral administration of melatonin during hypoxic pregnancy (10% oxygen) was protective against cardiovascular dysfunction in the offspring in adulthood. The data showed that melatonin was protective against the development of dilated cardiomyopathy, alterations in cardiac endothelial nitric oxide synthase (eNOS) expression and vascular dysfunction in the rat adult offspring at four months of age [<a href="#B34" class="usa-link" aria-describedby="B34">34</a>]. Melatonin also improved cardiomyocyte calcium handling in hypoxic rat pregnancy (13%) [<a href="#B35" class="usa-link" aria-describedby="B35">35</a>]. Importantly, these effects of melatonin were apparent at doses less than those recommended for the short-term treatment of jetlag, highlighting that melatonin treatment could be more of a suitable candidate for clinical translation than vitamin C. However, melatonin treatment not only weakens the fetal brain-sparing response to acute hypoxia [<a href="#B31" class="usa-link" aria-describedby="B31">31</a>], but concerns have accumulated around the safety of its long-term administration. Melatonin is an endogenous molecule that affects the transcription of many genes and many physiological functions, including the regulation of circadian rhythmicity [<a href="#B76" class="usa-link" aria-describedby="B76">76</a>]. Long-term administration of melatonin to pregnant women is therefore not currently recommended owing to a lack of safety studies and potential chrono-disruptive effects on the mother and fetus [<a href="#B78" class="usa-link" aria-describedby="B78">78</a>].</p></section><section id="s6-3"><h3 class="pmc_sec_title">(c). Allopurinol</h3>
<p>Some antioxidants aim to prevent the production of O₂<sup>•</sup>⁻ by specific pathways rather than aiming to remove ROS following their formation. Production of ROS by xanthine oxidase (XO) greatly increases under chronic hypoxia, and the antioxidant allopurinol can be used to prevent this [<a href="#B79" class="usa-link" aria-describedby="B79">79</a>,<a href="#B80" class="usa-link" aria-describedby="B80">80</a>]. Maternal oral administration of allopurinol to rats undergoing hypoxic (13% oxygen) pregnancy prevented the associated programmed increase in cardiac sympathetic dominance and impairment of cardiac function recovery from an ischaemic challenge [<a href="#B29" class="usa-link" aria-describedby="B29">29</a>]. A clinical trial investigating the effect of allopurinol administration during suspected hypoxic pregnancies on neurological outcomes of the offspring has shown no significant effects [<a href="#B81" class="usa-link" aria-describedby="B81">81</a>]. The safety of allopurinol administration during pregnancy has been debated owing to possible reports of teratogenicity, although recent studies have found little evidence to support this [<a href="#B82" class="usa-link" aria-describedby="B82">82</a>,<a href="#B83" class="usa-link" aria-describedby="B83">83</a>]. Interestingly, late gestation fetal sheep treated with allopurinol increased umbilical blood flow, suggestive of a basal XO-derived oxidant tone that limits umbilical perfusion under basal conditions [<a href="#B84" class="usa-link" aria-describedby="B84">84</a>]. However, during acute hypoxia, fetal sheep exposure to allopurinol diminished the fetal brain-sparing response [<a href="#B28" class="usa-link" aria-describedby="B28">28</a>], again reducing the impetus for this antioxidant strategy to be chosen for clinical translation.</p></section><section id="s6-4"><h3 class="pmc_sec_title">(d). Statins</h3>
<p>Statins have their antioxidant effect through increasing NO bioavailability [<a href="#B85" class="usa-link" aria-describedby="B85">85</a>]. Although there were initial concerns about embryotoxicity, observational data have demonstrated an absence of adverse pregnancy outcomes with inadvertent statin use [<a href="#B86" class="usa-link" aria-describedby="B86">86</a>]. Studies in the chicken embryo have reported that pravastatin treatment via the chorioallantoic circulation during hypoxic incubation increased NO bioavailability and improved NO-dependent vasodilatation [<a href="#B54" class="usa-link" aria-describedby="B54">54</a>]. Consistent with these data, studies using oral pravastatin treatment in a rodent model of pre-eclampsia found an increase in eNOS expression in the vasculature [<a href="#B55" class="usa-link" aria-describedby="B55">55</a>]. While initial studies suggested a promising ability of statins to reduce biomarkers found to be raised in pre-eclampsia, such as sFlt-1 and chemerin [<a href="#B87" class="usa-link" aria-describedby="B87">87</a>], recent clinical trials investigating the use of oral pravastatin in pregnancies with or at high risk of pre-eclampsia showed no beneficial effects including no reduction in these biomarkers [<a href="#B88" class="usa-link" aria-describedby="B88">88</a>,<a href="#B89" class="usa-link" aria-describedby="B89">89</a>]. The lack of data supporting the beneficial effect of statins when used in pregnancy, combined with their effects to weaken the fetal brain-sparing response [<a href="#B53" class="usa-link" aria-describedby="B53">53</a>], again, is currently prohibitive against their use in clinical practice.</p></section><section id="s6-5"><h3 class="pmc_sec_title">(e). Phenols</h3>
<p>Another antioxidant of interest is resveratrol, a naturally occurring phenol found in red wine that upregulates mitochondrial superoxide dismutase expression [<a href="#B90" class="usa-link" aria-describedby="B90">90</a>]. In preclinical studies using ovine pregnancy, subcutaneous administration of resveratrol increased uterine blood flow and improved fetal growth during healthy pregnancy [<a href="#B91" class="usa-link" aria-describedby="B91">91</a>] without effect on fetal haemodynamics when given as a bolus directly into the fetal femoral vein [<a href="#B49" class="usa-link" aria-describedby="B49">49</a>]. Additionally, resveratrol does not cross the placenta [<a href="#B49" class="usa-link" aria-describedby="B49">49</a>] and has been tested in several different animal models of complicated pregnancy (reviewed in [<a href="#B92" class="usa-link" aria-describedby="B92">92</a>]). Findings include dietary resveratrol improving fetal survival in a rodent model of chronic prenatal hypoxia [<a href="#B50" class="usa-link" aria-describedby="B50">50</a>] and improved cardiac function and recovery from an ischaemic reperfusion challenge in adult rat offspring who had been challenged with chronic fetal hypoxia combined with a high-fat diet post-weaning [<a href="#B51" class="usa-link" aria-describedby="B51">51</a>]. However, the safety of resveratrol treatment during pregnancy was questioned in a non-human primate study, which found concerning changes in fetal pancreatic development following maternal oral resveratrol administration [<a href="#B93" class="usa-link" aria-describedby="B93">93</a>]. Similarly, the results of clinical trials testing resveratrol in a variety of conditions have been contradictory (reviewed in [<a href="#B94" class="usa-link" aria-describedby="B94">94</a>]), with some studies finding benefits but others reporting adverse effects. The effects of resveratrol on the fetal brain-sparing effect remain unknown. Therefore, more research is needed to evaluate the efficacy of resveratrol treatment in pregnancy.</p></section><section id="s6-6"><h3 class="pmc_sec_title">(f). <em>N</em>-acetylcysteine</h3>
<p>It has been suggested that exogenous antioxidant treatment or agents that increase NO bioavailability may have too slow a reaction rate to protect against pro-oxidant mechanisms [<a href="#B95" class="usa-link" aria-describedby="B95">95</a>]. Therefore, an alternative approach may be to enhance the synthesis of endogenous antioxidant mechanisms at their very site of physiological production to protect against cardiovascular disease programmed by developmental hypoxia. One molecule of interest in this regard is <em>N</em>-acetylcysteine (NAC), which has been trialled clinically in human pregnancies with impending preterm birth affected by intrauterine infection and/or inflammation, showing improved neonatal outcome after short-term intravenous administration [<a href="#B96" class="usa-link" aria-describedby="B96">96</a>,<a href="#B97" class="usa-link" aria-describedby="B97">97</a>]. However, evidence on antenatal use in pregnancies at risk of chronic hypoxia is currently lacking, and a trial of NAC in women with severe pre-eclampsia showed no benefit [<a href="#B98" class="usa-link" aria-describedby="B98">98</a>]. The effect of NAC on the fetal brain-sparing response remains unknown. However, NAC reduced the pulsatility index in the umbilical artery of fetal guinea pigs exposed to chronic hypoxia induced by progressive uterine artery occlusion [<a href="#B44" class="usa-link" aria-describedby="B44">44</a>]. The precise molecular mechanisms of the antioxidant properties of NAC are uncertain. Nevertheless, it is thought to work partly as a precursor to the production of the antioxidant glutathione, as well as promoting free radical scavenging through its conversion to hydrogen sulfide and sulfane sulfur species [<a href="#B99" class="usa-link" aria-describedby="B99">99</a>–<a href="#B101" class="usa-link" aria-describedby="B101">101</a>]. Hydrogen sulfide is also an endothelial-derived vasorelaxant with similar effects to NO [<a href="#B102" class="usa-link" aria-describedby="B102">102</a>]. A recent study has shown that both human fetuses and chronically hypoxic chicken embryos with growth restriction have increased expression of the gene <em>CTH</em>, which is involved in hydrogen sulfide synthesis [<a href="#B43" class="usa-link" aria-describedby="B43">43</a>]. Furthermore, treatment with NAC restored impaired endothelial function in both human chorionic arterial segments from growth-restricted pregnancies and the femoral artery of the chronically hypoxic chicken embryo [<a href="#B43" class="usa-link" aria-describedby="B43">43</a>].</p></section><section id="s6-7"><h3 class="pmc_sec_title">(g). Phosphodiesterase inhibitors</h3>
<p>The phosphodiesterase-5 inhibitor sildenafil has been investigated as a therapy for pregnancies complicated by placental insufficiency and fetal growth restriction. Sildenafil inhibits O₂<sup>•</sup>⁻ production [<a href="#B103" class="usa-link" aria-describedby="B103">103</a>], NADPH oxidase ROS production [<a href="#B104" class="usa-link" aria-describedby="B104">104</a>] and enhances NO signalling [<a href="#B105" class="usa-link" aria-describedby="B105">105</a>]. Administration of sildenafil to the hypoxic chicken embryo via the chorioallantoic circulation improved peripheral vascular function, reduced measures of oxidative stress and improved NO bioavailability [<a href="#B46" class="usa-link" aria-describedby="B46">46</a>]. However, the effect of sildenafil administration during chronic hypoxia on the programming of adult cardiovascular disease has not been studied. Similarly, the effects of sildenafil administration on the fetal brain-sparing response during an acute hypoxic challenge have not been investigated, although an ovine study in late gestation demonstrated that sildenafil infusion increased fetal femoral blood flow during chronic hypoxia, suggesting possible impairment of fetal brain sparing during chronic hypoxia [<a href="#B45" class="usa-link" aria-describedby="B45">45</a>].</p>
<p>Early studies suggested that sildenafil might protect fetal growth in human [<a href="#B106" class="usa-link" aria-describedby="B106">106</a>], ovine and rodent [<a href="#B107" class="usa-link" aria-describedby="B107">107</a>–<a href="#B109" class="usa-link" aria-describedby="B109">109</a>] pregnancies affected by fetal growth restriction. However, a series of international randomized trials (Sildenafil TheRapy In Dismal prognosis Early onset fetal growth Restriction [STRIDER]) disappointingly found no delay in gestational age at birth or improved birthweight in treated pregnancies affected by early-onset fetal growth restriction and abnormal umbilical artery Doppler blood flow velocity. Of concern, there was an increased risk of pulmonary hypertension in neonates of mothers who received sildenafil treatment (18.8% versus 5.1% in the placebo group, <em>p</em> = 0.008), and the Dutch STRIDER trial was terminated early for this reason [<a href="#B48" class="usa-link" aria-describedby="B48">48</a>,<a href="#B110" class="usa-link" aria-describedby="B110">110</a>–<a href="#B113" class="usa-link" aria-describedby="B113">113</a>]. More recently, clinical trials in Japan are studying the longer acting phosphodiesterase-5 inhibitor tadalafil [<a href="#B114" class="usa-link" aria-describedby="B114">114</a>,<a href="#B115" class="usa-link" aria-describedby="B115">115</a>], which has a half-life of 14−15 versus 2−4 h for sildenafil. The initial phase IIa TheTADAlafil treatment for Fetuses with early-onset growth Restriction (TADAFER) placebo double-blind randomized placebo control trial recruited women with fetal growth restriction up to 34 weeks of gestation, but only 5% had abnormal umbilical artery Doppler blood flow velocity, and 25% had abnormal uterine artery Doppler blood flow velocity, a very different population to those recruited to the STRIDER trials [<a href="#B116" class="usa-link" aria-describedby="B116">116</a>]. Tadalafil decreased the perinatal death rate, possibly via prolonging pregnancy, and tadalafil decreased the umbilical artery pulsatility index when the estimated fetal weight was very small (−2 s.d.). The results of the larger TADAFER IIb study await completion and analysis (Cochrane Central Register of Controlled Trials CN-01970876).</p></section><section id="s6-8"><h3 class="pmc_sec_title">(h). MitoQ</h3>
<p>Mitochondria are an attractive target for antioxidant treatment of complicated pregnancy because mitochondria are a major source of cellular oxidative stress [<a href="#B117" class="usa-link" aria-describedby="B117">117</a>], and the production of mitochondrial ROS is known to increase under hypoxic conditions [<a href="#B64" class="usa-link" aria-describedby="B64">64</a>]. Treating mitochondrial O₂<sup>•</sup>⁻ with oral pyrroloquinoline quinone improved fetal cardiomyocyte endowment in spontaneously growth-restricted guinea pigs [<a href="#B52" class="usa-link" aria-describedby="B52">52</a>]; however, its effect on the fetal brain-sparing response is unknown. Other conventional antioxidant therapies are largely ineffective against mitochondrial oxidative stress as only a small proportion is able to penetrate mitochondria. However, MitoQ, which readily accumulates in the mitochondria, is an antioxidant which specifically targets mitochondria-derived oxidative stress without preventing the O₂<sup>•</sup>⁻ and NO reaction required for the brain-sparing response [<a href="#B36" class="usa-link" aria-describedby="B36">36</a>,<a href="#B61" class="usa-link" aria-describedby="B61">61</a>]. Preclinical studies found that maternal oral and intravenous administration of MitoQ can cross the placenta and reach a therapeutic concentration in fetal tissues [<a href="#B36" class="usa-link" aria-describedby="B36">36</a>]. MitoQ administered to the hypoxic chicken embryo via the chorioallantoic circulation improved vascular and cardiac function, while intravenous MitoQ administration to hypoxic pregnant sheep prevented the programming of hypertension in the adult offspring via enhanced NO signalling pathways [<a href="#B36" class="usa-link" aria-describedby="B36">36</a>]. Studies in rats have also shown improved cardiovascular function in adult offspring of hypoxic pregnancies treated with oral MitoQ, including protection against increased α<sub>1</sub>-adrenergic reactivity, cardiac sympathetic dominance and improved peripheral vasodilatation [<a href="#B37" class="usa-link" aria-describedby="B37">37</a>,<a href="#B38" class="usa-link" aria-describedby="B38">38</a>]. Of note, encapsulating MitoQ in nanoparticles (nMitoQ) that enable MitoQ to specifically treat oxidative stress within the placenta, but not the fetus, appears to also protect the fetus exposed to maternal hypoxia from future cardiovascular disease [<a href="#B38" class="usa-link" aria-describedby="B38">38</a>–<a href="#B42" class="usa-link" aria-describedby="B42">42</a>]. MitoQ has passed through formal animal toxicity, human phase 1 studies, and three published phase 2 studies in non-pregnant adults with no toxicity reported [<a href="#B118" class="usa-link" aria-describedby="B118">118</a>]. Additionally, MitoQ has also been available as an oral supplement since 2013, with no toxicity reported at the oral doses recommended [<a href="#B119" class="usa-link" aria-describedby="B119">119</a>]. The combination of MitoQ being the only antioxidant studied to date that does not impair the fetal brain-sparing response to hypoxia [<a href="#B36" class="usa-link" aria-describedby="B36">36</a>], coupled with it being a drug already approved for use in human clinical trials to test its safety and efficacy under various disease states [<a href="#B61" class="usa-link" aria-describedby="B61">61</a>], makes it an attractive candidate for human clinical translation for protecting cardiovascular dysfunction in adult offspring programmed by hypoxic pregnancy.</p></section></section><section id="s7"><h2 class="pmc_sec_title">7.  The path to clinical translation</h2>
<p>There are challenges when taking maternal antioxidant therapy into clinical practice to target fetal origins of an increased cardiovascular risk in offspring. This is most difficult when considering therapeutics that may be untested in pregnancy or even novel to human use. First, the mantra for prenatal therapy is safety first [<a href="#B120" class="usa-link" aria-describedby="B120">120</a>]. The trial team must consider not only the safety of the mother and her current fetus as well as the future neonate, child and adult the fetus would become but also the effects on any future sibling offspring. For instance, via an impact of the therapy on the maternal ovaries and thereby her future reproductive capacity, or transgenerational consequences through effects on the fetal primordial follicles if the fetus is female. Safety is commonly assessed in preclinical animal models through toxicology and/or reproductive toxicology studies, with specific guidelines available on the types of studies, including high dose exposure, length of time and expected analyses [<a href="#B121" class="usa-link" aria-describedby="B121">121</a>]. The development of <em>in silico</em> computational models to predict <em>in vivo</em> drug effects and <em>ex vivo</em> placental perfusion to assess short-term drug safety goes some way to reducing animal use according to 3Rs principles [<a href="#B122" class="usa-link" aria-describedby="B122">122</a>], but cannot completely replace them in the current International Council for Harmonization guidance.</p>
<p>Second, the therapy must be effective by improving fetal/neonatal outcome, and if possible, by improving maternal health or certainly without detriment to her well-being. Preclinical models that can optimally mimic developmental programming by chronic fetal hypoxia in humans are required, but no one model species is able to fully recapitulate this. Genetically modified mice offer a well-characterized phenotype/genotype, and rats are useful from a regulatory perspective and have a greater size for manipulation. However, guinea pigs have the most similar rodent placenta to humans [<a href="#B123" class="usa-link" aria-describedby="B123">123</a>,<a href="#B124" class="usa-link" aria-describedby="B124">124</a>]. Sheep are very well understood for fetal physiology and amenable to surgical instrumentation for long-term physiological recording [<a href="#B125" class="usa-link" aria-describedby="B125">125</a>]. Although expensive and with ethical concerns, non-human primates are commonly used for safety testing, providing data for regulatory submissions [<a href="#B126" class="usa-link" aria-describedby="B126">126</a>].</p>
<p>Another concern is that the harm in the adult offspring associated with fetal programming from chronic hypoxia can take many years and sometimes decades to manifest, rendering trials unfeasible and prohibitively expensive. Therefore, short-term surrogate markers of safety and effectiveness are needed that are closely associated with the fetal programming effect, but which can be detected optimally either <em>in utero</em> or at/soon after birth. Another reason to have a short-term surrogate marker is that in a first-in-human clinical trial of a novel therapeutic, patient dosing and dose escalation may be advised serially, with safety/effectiveness observed after each patient, before moving to the next patient/higher dose. Short-term fetal endpoints can be difficult to assess. Direct quantification of fetal oxygen saturation or fetal cardiac remodelling is currently not possible, but changes in fetal growth velocity, cardiac function and circulatory redistribution can be observed using ultrasound and Doppler blood flow velocimetry [<a href="#B127" class="usa-link" aria-describedby="B127">127</a>]. Therefore, triallists may need to rely on neonatal circulating protein markers of neural and cardiac injury, such as S100b [<a href="#B128" class="usa-link" aria-describedby="B128">128</a>] and troponin T [<a href="#B129" class="usa-link" aria-describedby="B129">129</a>], respectively.</p>
<p>Testing existing drugs used for other purposes, namely drug repurposing, offers a potentially shorter route to market. Identification of the drug candidate increasingly uses computational and experimental approaches such as artificial intelligence algorithms and other bioinformatics tools. Repurposed drugs have the advantage of already having passed many safety and toxicology tests, and there may be data on drug use in pregnancy via post-marketing surveillance.</p>
<p>Once initial efficacy is demonstrated, the potential route to market follows a well-trodden path and includes scientific advice with regard to toxicology/reproductive toxicology study plans and drug manufacture/quality testing (<a href="#F3" class="usa-link">figure 3</a>). Clinical trial design must include identifying the population at risk to define the inclusion and exclusion criteria for the protocol. Target product profiles (TPPs, such as those recently developed for the prevention and treatment of pre-eclampsia, are important tools to drive new drug development by specifying upfront the characteristics that new products should take [<a href="#B130" class="usa-link" aria-describedby="B130">130</a>]. To date, no TPP exists for fetal hypoxia. For early phase trials where drugs are being used for the first time in humans, dose-escalation studies are usually performed. The baseline adverse event rate of the maternal and fetal condition should be well understood ahead of drug testing to assist with determining the acceptable toxicity level and to balance the risk versus benefit for the drug in the at-risk population [<a href="#B131" class="usa-link" aria-describedby="B131">131</a>]. Fetal hypoxia may occur via a number of mechanisms such as placental insufficiency or fetal structural anomalies; therefore, choosing the population in whom to test the drug requires careful thought. Engagement with the patient population and stakeholders and involving them early during the clinical translation pathway is strongly recommended. Patients can become advocates of the need for therapy; they provide information on what level of harm may be acceptable to them and improve decision-making about the ethics of a drug treatment, clinical trial participation and trial outcome measures [<a href="#B132" class="usa-link" aria-describedby="B132">132</a>]. Their view may also be pivotal in getting clinical trial ethical approval. Phase III trials often include an element of randomizing patients to a treatment or placebo group to reduce the risk of bias. Getting patient input into decisions as to whether randomization is possible and how it might be achieved (e.g. low versus high dose drug, early versus delayed randomization) is critical to ensure that a trial recruits well.</p>
<figure class="fig xbox font-sm" id="F3" title="Path to clinical translation. A schematic representation of the key stages in drug development, from preclinical research to commercialization."><h3 class="obj_head">Figure 3. </h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12368550_rstb.2024.0183.f003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a32/12368550/cb8200f7ac4d/rstb.2024.0183.f003.jpg" loading="lazy" height="510" width="756" alt="Path to clinical translation. A schematic representation of the key stages in drug development, from preclinical research to commercialization."></a></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Path to clinical translation. A schematic representation of the key stages in drug development, from preclinical research to commercialization. The process is divided into five phases: preclinical data, translation, clinical trial, the drug and commercialization. Each phase is associated with critical questions specific to treating fetal hypoxia that guide decision-making. In the preclinical stage, essential considerations include the selection of animal models, dose range and potential effects on maternal and fetal health. The translation phase addresses the feasibility of clinical application, regulatory guidance and stakeholder engagement. The clinical trial phase focuses on study design, target population, safety and efficacy markers. The drug phase involves regulatory approval, manufacturing optimization and prior human use. Finally, the commercialization phase ensures patent protection, funding and market positioning, including orphan drug status. This framework highlights the multidisciplinary approach required for successful drug development. Created in <a href="https://BioRender.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://BioRender.com</a>.</p></figcaption></figure><p>Invention disclosure and patent registration are useful to commercialize a therapeutic approach, but the length of time to develop a drug, particularly with relevance to maternal and fetal indications, may mean that there is limited time left on the patent by the time it reaches the market. Securing orphan drug designation will smooth the regulatory submissions, and in Europe, for example, it provides 10 years of market exclusivity to protect companies from competition, which can aid the recovery of expensive research costs [<a href="#B133" class="usa-link" aria-describedby="B133">133</a>]. A recent estimate for developing a new drug found that the cost in the last 20 years was approximately $173 million (range, $73 million for genitourinary to $298 million for pain and anaesthesia), inclusive of post-marketing studies, increasing to $516 million when the cost of failures was included [<a href="#B134" class="usa-link" aria-describedby="B134">134</a>]. The cost of drug development for a maternal and fetal condition is likely to be higher given the complexity and extra challenges, although the need is greater than for many paediatric or adult illnesses.</p></section><section id="s8"><h2 class="pmc_sec_title">8.  Summary</h2>
<p>In conclusion, the interaction between O₂<sup>•</sup>⁻ and NO at the level of the vasculature plays a critical role in the regulation of fetal peripheral vasoconstriction, which contributes to the fetal brain-sparing response to acute hypoxia. While conventional antioxidants weaken the fetal peripheral vasoconstriction, the mitochondria-targeted antioxidant MitoQ has emerged as a promising candidate for protecting against the long-term adverse cardiovascular consequences of fetal hypoxia without impairing the fetal brain-sparing response to acute hypoxia. However, translating maternal antioxidant therapy into clinical practice presents several challenges, including the identification of reliable short-term surrogate markers to facilitate early-stage clinical trials. Repurposing existing drugs, such as MitoQ, offers a potential pathway to accelerate clinical translation, as these compounds have already undergone extensive safety evaluations, including human clinical trials. However, further research is required to establish definitive safety and efficacy profiles specific to its treatment during pregnancy. Future research efforts should focus on refining antioxidant therapies, identifying reliable biomarkers for fetal programming and establishing robust clinical trial frameworks. Addressing these challenges will be essential in developing effective strategies to improve long-term cardiovascular health outcomes for individuals exposed to fetal hypoxia.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Grant awarded to D.A.G. fro the British Heart Foundation RG/17/8/32924A.L.D. is supported by the National Institute for Health and Care Research University College London Hospitals Biomedical Research Centre.</p></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Kimberley J. Botting-Lawford, Email: k.botting@ucl.ac.uk.</p>
<p>Katie L. Skeffington, Email: katie.skeffington@bristol.ac.uk.</p>
<p>Michael P. Murphy, Email: mpm37@cam.ac.uk.</p>
<p>Anna L. David, Email: a.david@ucl.ac.uk.</p>
<p>Dino A. Giussani, Email: dag26@cam.ac.uk.</p></section><section id="s9"><h2 class="pmc_sec_title">Ethics</h2>
<p>This work did not require ethical approval from a human subject or animal welfare committee.</p></section><section id="s10"><h2 class="pmc_sec_title">Data accessibility</h2>
<p>All data presented in this review have been previously published and can be sourced from the following articles:</p>
<p>MitoQ; [<a href="#B36" class="usa-link" aria-describedby="B36">36</a>], vitamin C; [<a href="#B27" class="usa-link" aria-describedby="B27">27</a>], melatonin; [<a href="#B31" class="usa-link" aria-describedby="B31">31</a>], allopurinol; [<a href="#B28" class="usa-link" aria-describedby="B28">28</a>], pravastatin; [<a href="#B53" class="usa-link" aria-describedby="B53">53</a>].</p></section><section id="s11"><h2 class="pmc_sec_title">Declaration of AI use</h2>
<p>We have not used AI-assisted technologies in creating this article.</p></section><section id="s12"><h2 class="pmc_sec_title">Authors’ contributions</h2>
<p>K.J.B.-L.: conceptualization, data curation, formal analysis, writing—original draft, writing—review and editing; K.L.S.: writing—original draft, writing—review and editing; M.P.M.: writing—original draft, writing—review and editing; A.L.D.: conceptualization, writing—original draft, writing—review and editing; D.A.G.: conceptualization, funding acquisition, writing—original draft, writing—review and editing.</p>
<p>All authors gave final approval for publication and agreed to be held accountable for the work performed therein.</p></section><section id="s13"><h2 class="pmc_sec_title">Conflict of interest declaration</h2>
<p>M.P.M. is chair of the SAB of MitoQ Inc and holds stock in that company.</p></section><section id="s14"><h2 class="pmc_sec_title">Funding</h2>
<p>No funding has been received for this article.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>
Cerritelli F, Frasch MG, Antonelli MC, Viglione C, Vecchi S, Chiera M, Manzotti A. 2021. 
A review on the vagus nerve and autonomic nervous system during fetal development: searching for critical windows. Front. Neurosci.
15, 721605. ( 10.3389/fnins.2021.721605)
</cite> [<a href="https://doi.org/10.3389/fnins.2021.721605" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8488382/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34616274/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Neurosci.&amp;title=A%20review%20on%20the%20vagus%20nerve%20and%20autonomic%20nervous%20system%20during%20fetal%20development:%20searching%20for%20critical%20windows&amp;volume=15&amp;publication_year=2021&amp;pages=721605&amp;pmid=34616274&amp;doi=10.3389/fnins.2021.721605&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>
Mayhew TM, Charnock-Jones DS, Kaufmann P. 2004. 
Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta
25, 127–139. ( 10.1016/j.placenta.2003.10.010)
</cite> [<a href="https://doi.org/10.1016/j.placenta.2003.10.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14972445/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Placenta&amp;title=Aspects%20of%20human%20fetoplacental%20vasculogenesis%20and%20angiogenesis.%20III.%20Changes%20in%20complicated%20pregnancies&amp;volume=25&amp;publication_year=2004&amp;pages=127-139&amp;pmid=14972445&amp;doi=10.1016/j.placenta.2003.10.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>
Shaw CJ, Allison BJ, Itani N, Botting KJ, Niu Y, Lees CC, Giussani DA. 2018. 
Altered autonomic control of heart rate variability in the chronically hypoxic fetus. J. Physiol.
596, 6105–6119. ( 10.1113/jp275659)
</cite> [<a href="https://doi.org/10.1113/jp275659" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6265555/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29604064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Altered%20autonomic%20control%20of%20heart%20rate%20variability%20in%20the%20chronically%20hypoxic%20fetus&amp;volume=596&amp;publication_year=2018&amp;pages=6105-6119&amp;pmid=29604064&amp;doi=10.1113/jp275659&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>
Botting KJ, McMillen IC, Forbes H, Nyengaard JR, Morrison JL. 2014. 
Chronic hypoxemia in late gestation decreases cardiomyocyte number but does not change expression of hypoxia‐responsive genes. J. Am. Heart Assoc.
3. ( 10.1161/jaha.113.000531)</cite> [<a href="https://doi.org/10.1161/jaha.113.000531" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4310356/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25085511/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Heart%20Assoc.&amp;title=Chronic%20hypoxemia%20in%20late%20gestation%20decreases%20cardiomyocyte%20number%20but%20does%20not%20change%20expression%20of%20hypoxia%E2%80%90responsive%20genes&amp;volume=3&amp;publication_year=2014&amp;pmid=25085511&amp;doi=10.1161/jaha.113.000531&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>
Giussani DA. 2021. 
Breath of life: heart disease link to developmental hypoxia. Circulation
144, 1429–1443. ( 10.1161/circulationaha.121.054689)
</cite> [<a href="https://doi.org/10.1161/circulationaha.121.054689" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8542082/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34694887/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Breath%20of%20life:%20heart%20disease%20link%20to%20developmental%20hypoxia&amp;volume=144&amp;publication_year=2021&amp;pages=1429-1443&amp;pmid=34694887&amp;doi=10.1161/circulationaha.121.054689&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>
Giussani DA, et al. 2012. 
Developmental programming of cardiovascular dysfunction by prenatal hypoxia and oxidative stress. PLoS ONE
7, e31017. ( 10.1371/journal.pone.0031017)
</cite> [<a href="https://doi.org/10.1371/journal.pone.0031017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3278440/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22348036/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Developmental%20programming%20of%20cardiovascular%20dysfunction%20by%20prenatal%20hypoxia%20and%20oxidative%20stress&amp;volume=7&amp;publication_year=2012&amp;pages=e31017&amp;pmid=22348036&amp;doi=10.1371/journal.pone.0031017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>
Morton JS, Rueda-Clausen CF, Davidge ST. 2010. 
Mechanisms of endothelium-dependent vasodilation in male and female, young and aged offspring born growth restricted. Am. J. Physiol. Regul. Integr. Comp. Physiol.
298, R930–R938. ( 10.1152/ajpregu.00641.2009)
</cite> [<a href="https://doi.org/10.1152/ajpregu.00641.2009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20053962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Physiol.%20Regul.%20Integr.%20Comp.%20Physiol.&amp;title=Mechanisms%20of%20endothelium-dependent%20vasodilation%20in%20male%20and%20female,%20young%20and%20aged%20offspring%20born%20growth%20restricted&amp;volume=298&amp;publication_year=2010&amp;pages=R930-R938&amp;pmid=20053962&amp;doi=10.1152/ajpregu.00641.2009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>
Sutovska H, Babarikova K, Zeman M, Molcan L. 2022. 
Prenatal hypoxia affects foetal cardiovascular regulatory mechanisms in a sex- and circadian-dependent manner: a review. Int. J. Mol. Sci.
23, 2885. ( 10.3390/ijms23052885)
</cite> [<a href="https://doi.org/10.3390/ijms23052885" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8910900/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35270026/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Prenatal%20hypoxia%20affects%20foetal%20cardiovascular%20regulatory%20mechanisms%20in%20a%20sex-%20and%20circadian-dependent%20manner:%20a%20review&amp;volume=23&amp;publication_year=2022&amp;pages=2885&amp;pmid=35270026&amp;doi=10.3390/ijms23052885&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>
Paz AA, Jiménez TA, Ibarra-Gonzalez J, Astudillo-Maya C, Beñaldo FA, Figueroa EG, Llanos AJ, Gonzalez-Candia A, Herrera EA. 2025. 
Gestational hypoxia elicits long-term cardiovascular dysfunction in female guinea pigs. Life Sci.
361, 123282. ( 10.1016/j.lfs.2024.123282)
</cite> [<a href="https://doi.org/10.1016/j.lfs.2024.123282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39615619/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Life%20Sci.&amp;title=Gestational%20hypoxia%20elicits%20long-term%20cardiovascular%20dysfunction%20in%20female%20guinea%20pigs&amp;volume=361&amp;publication_year=2025&amp;pages=123282&amp;pmid=39615619&amp;doi=10.1016/j.lfs.2024.123282&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>
Chen X, Zhang L, Wang C. 2019. 
Prenatal hypoxia-induced epigenomic and transcriptomic reprogramming in rat fetal and adult offspring hearts. Sci. Data
6, 238. ( 10.1038/s41597-019-0253-9)
</cite> [<a href="https://doi.org/10.1038/s41597-019-0253-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6820751/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31664036/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Data&amp;title=Prenatal%20hypoxia-induced%20epigenomic%20and%20transcriptomic%20reprogramming%20in%20rat%20fetal%20and%20adult%20offspring%20hearts&amp;volume=6&amp;publication_year=2019&amp;pages=238&amp;pmid=31664036&amp;doi=10.1038/s41597-019-0253-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>
Fernandez-Twinn DS, Constância M, Ozanne SE. 2015. 
Intergenerational epigenetic inheritance in models of developmental programming of adult disease. Semin. Cell Dev. Biol.
43, 85–95. ( 10.1016/j.semcdb.2015.06.006)
</cite> [<a href="https://doi.org/10.1016/j.semcdb.2015.06.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5844462/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26135290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Semin.%20Cell%20Dev.%20Biol.&amp;title=Intergenerational%20epigenetic%20inheritance%20in%20models%20of%20developmental%20programming%20of%20adult%20disease&amp;volume=43&amp;publication_year=2015&amp;pages=85-95&amp;pmid=26135290&amp;doi=10.1016/j.semcdb.2015.06.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>
Patterson AJ, Chen M, Xue Q, Xiao D, Zhang L. 2010. 
Chronic prenatal hypoxia induces epigenetic programming of PKCepsilon gene repression in rat hearts. Circ. Res.
107, 365–373. ( 10.1161/circresaha.110.221259)
</cite> [<a href="https://doi.org/10.1161/circresaha.110.221259" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2919213/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20538683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Res.&amp;title=Chronic%20prenatal%20hypoxia%20induces%20epigenetic%20programming%20of%20PKCepsilon%20gene%20repression%20in%20rat%20hearts&amp;volume=107&amp;publication_year=2010&amp;pages=365-373&amp;pmid=20538683&amp;doi=10.1161/circresaha.110.221259&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>
Giussani DA, Davidge ST. 2013. 
Developmental programming of cardiovascular disease by prenatal hypoxia. J. Dev. Orig. Health Dis.
4, 328–337. ( 10.1017/s204017441300010x)
</cite> [<a href="https://doi.org/10.1017/s204017441300010x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24970726/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Dev.%20Orig.%20Health%20Dis.&amp;title=Developmental%20programming%20of%20cardiovascular%20disease%20by%20prenatal%20hypoxia&amp;volume=4&amp;publication_year=2013&amp;pages=328-337&amp;pmid=24970726&amp;doi=10.1017/s204017441300010x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>
Tejero J, Shiva S, Gladwin MT. 2019. 
Sources of vascular nitric oxide and reactive oxygen species and their regulation. Physiol. Rev.
99, 311–379. ( 10.1152/physrev.00036.2017)
</cite> [<a href="https://doi.org/10.1152/physrev.00036.2017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6442925/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30379623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physiol.%20Rev.&amp;title=Sources%20of%20vascular%20nitric%20oxide%20and%20reactive%20oxygen%20species%20and%20their%20regulation&amp;volume=99&amp;publication_year=2019&amp;pages=311-379&amp;pmid=30379623&amp;doi=10.1152/physrev.00036.2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>
Lindsay RT, Rhodes CJ. 2025. 
Reactive oxygen species (ROS) in metabolic disease-don’t shoot the metabolic messenger. Int. J. Mol. Sci.
26. ( 10.3390/ijms26062622)</cite> [<a href="https://doi.org/10.3390/ijms26062622" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11942130/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40141264/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Reactive%20oxygen%20species%20(ROS)%20in%20metabolic%20disease-don%E2%80%99t%20shoot%20the%20metabolic%20messenger&amp;volume=26&amp;publication_year=2025&amp;pmid=40141264&amp;doi=10.3390/ijms26062622&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>
Sena LA, Chandel NS. 2012. 
Physiological roles of mitochondrial reactive oxygen species. Mol. Cell
48, 158–167. ( 10.1016/j.molcel.2012.09.025)
</cite> [<a href="https://doi.org/10.1016/j.molcel.2012.09.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3484374/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23102266/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell&amp;title=Physiological%20roles%20of%20mitochondrial%20reactive%20oxygen%20species&amp;volume=48&amp;publication_year=2012&amp;pages=158-167&amp;pmid=23102266&amp;doi=10.1016/j.molcel.2012.09.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>
Kapitsinou PP, et al. 2010. 
Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood
116, 3039–3048. ( 10.1182/blood-2010-02-270322)
</cite> [<a href="https://doi.org/10.1182/blood-2010-02-270322" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2974609/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20628150/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Hepatic%20HIF-2%20regulates%20erythropoietic%20responses%20to%20hypoxia%20in%20renal%20anemia&amp;volume=116&amp;publication_year=2010&amp;pages=3039-3048&amp;pmid=20628150&amp;doi=10.1182/blood-2010-02-270322&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>
Sousa Fialho M da L, Abd Jamil AH, Stannard GA, Heather LC. 2019. 
Hypoxia-inducible factor 1 signalling, metabolism and its therapeutic potential in cardiovascular disease. Biochim. Biophys. Acta Mol. Basis Dis.
1865, 831–843. ( 10.1016/j.bbadis.2018.09.024)
</cite> [<a href="https://doi.org/10.1016/j.bbadis.2018.09.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30266651/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochim.%20Biophys.%20Acta%20Mol.%20Basis%20Dis.&amp;title=Hypoxia-inducible%20factor%201%20signalling,%20metabolism%20and%20its%20therapeutic%20potential%20in%20cardiovascular%20disease&amp;volume=1865&amp;publication_year=2019&amp;pages=831-843&amp;pmid=30266651&amp;doi=10.1016/j.bbadis.2018.09.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>
Skeffington KL, Beck C, Itani N, Niu Y, Shaw CJ, Giussani DA. 2020. 
Hypertension programmed in adult hens by isolated effects of developmental hypoxia in ovo. Hypertension
76, 533–544. ( 10.1161/hypertensionaha.120.15045)
</cite> [<a href="https://doi.org/10.1161/hypertensionaha.120.15045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7340221/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32536277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Hypertension%20programmed%20in%20adult%20hens%20by%20isolated%20effects%20of%20developmental%20hypoxia%20in%20ovo&amp;volume=76&amp;publication_year=2020&amp;pages=533-544&amp;pmid=32536277&amp;doi=10.1161/hypertensionaha.120.15045&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>
Thompson LP, Al-Hasan Y. 2012. 
Impact of oxidative stress in fetal programming. J. Pregnancy
2012, 1–8. ( 10.1155/2012/582748)</cite> [<a href="https://doi.org/10.1155/2012/582748" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3403156/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22848830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pregnancy&amp;title=Impact%20of%20oxidative%20stress%20in%20fetal%20programming&amp;volume=2012&amp;publication_year=2012&amp;pages=1-8&amp;pmid=22848830&amp;doi=10.1155/2012/582748&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>
Thompson JA, Webb RC. 2013. 
Potential role of toll-like receptors in programming of vascular dysfunction. Clin. Sci.
125, 19–25. ( 10.1042/cs20120673)</cite> [<a href="https://doi.org/10.1042/cs20120673" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4004342/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23485061/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Sci.&amp;title=Potential%20role%20of%20toll-like%20receptors%20in%20programming%20of%20vascular%20dysfunction&amp;volume=125&amp;publication_year=2013&amp;pages=19-25&amp;pmid=23485061&amp;doi=10.1042/cs20120673&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>
Giussani DA. 2016. 
The fetal brain sparing response to hypoxia: physiological mechanisms. J. Physiol.
594, 1215–1230. ( 10.1113/jp271099)
</cite> [<a href="https://doi.org/10.1113/jp271099" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4721497/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26496004/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=The%20fetal%20brain%20sparing%20response%20to%20hypoxia:%20physiological%20mechanisms&amp;volume=594&amp;publication_year=2016&amp;pages=1215-1230&amp;pmid=26496004&amp;doi=10.1113/jp271099&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>
Giussani DA, Spencer JA, Moore PJ, Bennet L, Hanson MA. 1993. 
Afferent and efferent components of the cardiovascular reflex responses to acute hypoxia in term fetal sheep. J. Physiol.
461, 431–449. ( 10.1113/jphysiol.1993.sp019521)
</cite> [<a href="https://doi.org/10.1113/jphysiol.1993.sp019521" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1175265/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8350271/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Afferent%20and%20efferent%20components%20of%20the%20cardiovascular%20reflex%20responses%20to%20acute%20hypoxia%20in%20term%20fetal%20sheep&amp;volume=461&amp;publication_year=1993&amp;pages=431-449&amp;pmid=8350271&amp;doi=10.1113/jphysiol.1993.sp019521&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>
Pearce W. 1995. 
Mechanisms of hypoxic cerebral vasodilatation. Pharmacol. Ther.
65, 75–91. ( 10.1016/0163-7258(94)00058-b)
</cite> [<a href="https://doi.org/10.1016/0163-7258(94)00058-b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7716183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol.%20Ther.&amp;title=Mechanisms%20of%20hypoxic%20cerebral%20vasodilatation&amp;volume=65&amp;publication_year=1995&amp;pages=75-91&amp;pmid=7716183&amp;doi=10.1016/0163-7258(94)00058-b&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>
Bartesaghi S, Radi R. 2018. 
Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration. Redox Biol.
14, 618–625. ( 10.1016/j.redox.2017.09.009)
</cite> [<a href="https://doi.org/10.1016/j.redox.2017.09.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5694970/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29154193/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Redox%20Biol.&amp;title=Fundamentals%20on%20the%20biochemistry%20of%20peroxynitrite%20and%20protein%20tyrosine%20nitration&amp;volume=14&amp;publication_year=2018&amp;pages=618-625&amp;pmid=29154193&amp;doi=10.1016/j.redox.2017.09.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>
Morrison S, Gardner DS, Fletcher AJW, Bloomfield MR, Giussani DA. 2003. 
Enhanced nitric oxide activity offsets peripheral vasoconstriction during acute hypoxaemia via chemoreflex and adrenomedullary actions in the sheep fetus. J. Physiol.
547, 283–291. ( 10.1113/jphysiol.2002.032615)
</cite> [<a href="https://doi.org/10.1113/jphysiol.2002.032615" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2342630/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12562956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Enhanced%20nitric%20oxide%20activity%20offsets%20peripheral%20vasoconstriction%20during%20acute%20hypoxaemia%20via%20chemoreflex%20and%20adrenomedullary%20actions%20in%20the%20sheep%20fetus&amp;volume=547&amp;publication_year=2003&amp;pages=283-291&amp;pmid=12562956&amp;doi=10.1113/jphysiol.2002.032615&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>
Thakor AS, Richter HG, Kane AD, Dunster C, Kelly FJ, Poston L, Giussani DA. 2010. 
Redox modulation of the fetal cardiovascular defence to hypoxaemia. J. Physiol.
588, 4235–4247. ( 10.1113/jphysiol.2010.196402)
</cite> [<a href="https://doi.org/10.1113/jphysiol.2010.196402" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3002453/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20807788/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Redox%20modulation%20of%20the%20fetal%20cardiovascular%20defence%20to%20hypoxaemia&amp;volume=588&amp;publication_year=2010&amp;pages=4235-4247&amp;pmid=20807788&amp;doi=10.1113/jphysiol.2010.196402&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>
Kane AD, Hansell JA, Herrera EA, Allison BJ, Niu Y, Brain KL, Kaandorp JJ, Derks JB, Giussani DA. 2014. 
Xanthine oxidase and the fetal cardiovascular defence to hypoxia in late gestation ovine pregnancy. J. Physiol.
592, 475–489. ( 10.1113/jphysiol.2013.264275)
</cite> [<a href="https://doi.org/10.1113/jphysiol.2013.264275" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3930434/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24247986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Xanthine%20oxidase%20and%20the%20fetal%20cardiovascular%20defence%20to%20hypoxia%20in%20late%20gestation%20ovine%20pregnancy&amp;volume=592&amp;publication_year=2014&amp;pages=475-489&amp;pmid=24247986&amp;doi=10.1113/jphysiol.2013.264275&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>
Niu Y, et al. 2018. 
Maternal allopurinol prevents cardiac dysfunction in adult male offspring programmed by chronic hypoxia during pregnancy. Hypertension
72, 971–978. ( 10.1161/hypertensionaha.118.11363)
</cite> [<a href="https://doi.org/10.1161/hypertensionaha.118.11363" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6135482/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30354714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Maternal%20allopurinol%20prevents%20cardiac%20dysfunction%20in%20adult%20male%20offspring%20programmed%20by%20chronic%20hypoxia%20during%20pregnancy&amp;volume=72&amp;publication_year=2018&amp;pages=971-978&amp;pmid=30354714&amp;doi=10.1161/hypertensionaha.118.11363&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>
Allison BJ, et al. 2016. 
Divergence of mechanistic pathways mediating cardiovascular aging and developmental programming of cardiovascular disease. FASEB J.
30, 1968–1975. ( 10.1096/fj.201500057)
</cite> [<a href="https://doi.org/10.1096/fj.201500057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5036970/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26932929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20J.&amp;title=Divergence%20of%20mechanistic%20pathways%20mediating%20cardiovascular%20aging%20and%20developmental%20programming%20of%20cardiovascular%20disease&amp;volume=30&amp;publication_year=2016&amp;pages=1968-1975&amp;pmid=26932929&amp;doi=10.1096/fj.201500057&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>
Thakor AS, Allison BJ, Niu Y, Botting KJ, Serón‐Ferré M, Herrera EA, Giussani DA. 2015. 
Melatonin modulates the fetal cardiovascular defense response to acute hypoxia. J. Pineal Res.
59, 80–90. ( 10.1111/jpi.12242)
</cite> [<a href="https://doi.org/10.1111/jpi.12242" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4528231/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25908097/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pineal%20Res.&amp;title=Melatonin%20modulates%20the%20fetal%20cardiovascular%20defense%20response%20to%20acute%20hypoxia&amp;volume=59&amp;publication_year=2015&amp;pages=80-90&amp;pmid=25908097&amp;doi=10.1111/jpi.12242&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<span class="label">32.</span><cite>
Candia AA, Arias PV, González-Candia C, Navarrete A, Ebensperger G, Reyes RV, Llanos AJ, González-Candia A, Herrera EA. 2022. 
Melatonin treatment during chronic hypoxic gestation improves neonatal cerebrovascular function. Vasc. Pharmacol.
144, 106971. ( 10.1016/j.vph.2022.106971)</cite> [<a href="https://doi.org/10.1016/j.vph.2022.106971" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35150933/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Vasc.%20Pharmacol.&amp;title=Melatonin%20treatment%20during%20chronic%20hypoxic%20gestation%20improves%20neonatal%20cerebrovascular%20function&amp;volume=144&amp;publication_year=2022&amp;pages=106971&amp;pmid=35150933&amp;doi=10.1016/j.vph.2022.106971&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<span class="label">33.</span><cite>
Itani N, Skeffington KL, Beck C, Niu Y, Giussani DA. 2016. 
Melatonin rescues cardiovascular dysfunction during hypoxic development in the chick embryo. J. Pineal Res.
60, 16–26. ( 10.1111/jpi.12283)
</cite> [<a href="https://doi.org/10.1111/jpi.12283" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4832387/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26444711/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pineal%20Res.&amp;title=Melatonin%20rescues%20cardiovascular%20dysfunction%20during%20hypoxic%20development%20in%20the%20chick%20embryo&amp;volume=60&amp;publication_year=2016&amp;pages=16-26&amp;pmid=26444711&amp;doi=10.1111/jpi.12283&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<span class="label">34.</span><cite>
Hansell JA, et al. 2022. 
Maternal melatonin: effective intervention against developmental programming of cardiovascular dysfunction in adult offspring of complicated pregnancy. J. Pineal Res.
72, e12766. ( 10.1111/jpi.12766)
</cite> [<a href="https://doi.org/10.1111/jpi.12766" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34634151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pineal%20Res.&amp;title=Maternal%20melatonin:%20effective%20intervention%20against%20developmental%20programming%20of%20cardiovascular%20dysfunction%20in%20adult%20offspring%20of%20complicated%20pregnancy&amp;volume=72&amp;publication_year=2022&amp;pages=e12766&amp;pmid=34634151&amp;doi=10.1111/jpi.12766&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<span class="label">35.</span><cite>
Lock MC, Patey OV, Smith KLM, Niu Y, Jaggs B, Trafford AW, Giussani DA, Galli GLJ. 2024. 
Maladaptive cardiomyocyte calcium handling in adult offspring of hypoxic pregnancy: protection by antenatal maternal melatonin. J. Physiol.
602, J. ( 10.1113/JP287325)</cite> [<a href="https://doi.org/10.1113/JP287325" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11649517/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39572933/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Maladaptive%20cardiomyocyte%20calcium%20handling%20in%20adult%20offspring%20of%20hypoxic%20pregnancy:%20protection%20by%20antenatal%20maternal%20melatonin&amp;volume=602&amp;publication_year=2024&amp;pages=J&amp;pmid=39572933&amp;doi=10.1113/JP287325&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<span class="label">36.</span><cite>
Botting KJ, et al. 2020. 
Translatable mitochondria-targeted protection against programmed cardiovascular dysfunction. Sci. Adv.
6, eabb1929. ( 10.1126/sciadv.abb1929)
</cite> [<a href="https://doi.org/10.1126/sciadv.abb1929" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7438086/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32875110/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Adv.&amp;title=Translatable%20mitochondria-targeted%20protection%20against%20programmed%20cardiovascular%20dysfunction&amp;volume=6&amp;publication_year=2020&amp;pages=eabb1929&amp;pmid=32875110&amp;doi=10.1126/sciadv.abb1929&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<span class="label">37.</span><cite>
Spiroski A, et al. 2021. 
Mitochondria antioxidant protection against cardiovascular dysfunction programmed by early‐onset gestational hypoxia. FASEB J.
35, e21446. ( 10.1096/fj.202002705r)
</cite> [<a href="https://doi.org/10.1096/fj.202002705r" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7612077/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33788974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20J.&amp;title=Mitochondria%20antioxidant%20protection%20against%20cardiovascular%20dysfunction%20programmed%20by%20early%E2%80%90onset%20gestational%20hypoxia&amp;volume=35&amp;publication_year=2021&amp;pages=e21446&amp;pmid=33788974&amp;doi=10.1096/fj.202002705r&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<span class="label">38.</span><cite>
Aljunaidy MM, Morton JS, Kirschenman R, Phillips T, Case CP, Cooke CLM, Davidge ST. 2018. 
Maternal treatment with a placental-targeted antioxidant (MitoQ) impacts offspring cardiovascular function in a rat model of prenatal hypoxia. Pharmacol. Res.
134, 332–342. ( 10.1016/j.phrs.2018.05.006)
</cite> [<a href="https://doi.org/10.1016/j.phrs.2018.05.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29778808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol.%20Res.&amp;title=Maternal%20treatment%20with%20a%20placental-targeted%20antioxidant%20(MitoQ)%20impacts%20offspring%20cardiovascular%20function%20in%20a%20rat%20model%20of%20prenatal%20hypoxia&amp;volume=134&amp;publication_year=2018&amp;pages=332-342&amp;pmid=29778808&amp;doi=10.1016/j.phrs.2018.05.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<span class="label">39.</span><cite>
Chatterjee P, et al. 2023. 
Sex-specific effects of prenatal hypoxia and a placental antioxidant treatment on cardiac mitochondrial function in the young adult offspring. Int. J. Mol. Sci.
24, 13624. ( 10.3390/ijms241713624)
</cite> [<a href="https://doi.org/10.3390/ijms241713624" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10487956/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37686430/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Sex-specific%20effects%20of%20prenatal%20hypoxia%20and%20a%20placental%20antioxidant%20treatment%20on%20cardiac%20mitochondrial%20function%20in%20the%20young%20adult%20offspring&amp;volume=24&amp;publication_year=2023&amp;pages=13624&amp;pmid=37686430&amp;doi=10.3390/ijms241713624&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<span class="label">40.</span><cite>
Hula N, Kirschenman R, Quon A, Spaans F, Phillips TJ, Case CP, Cooke CLM, Davidge ST. 2023. 
Placenta-targeted treatment with nMitoQ prevents an endothelin receptor-A pathway cardiac phenotype observed in adult male offspring exposed to hypoxia in utero. Am. J. Physiol. Heart Circ. Physiol.
325, H136–H141. ( 10.1152/ajpheart.00238.2023)
</cite> [<a href="https://doi.org/10.1152/ajpheart.00238.2023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37235521/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Physiol.%20Heart%20Circ.%20Physiol.&amp;title=Placenta-targeted%20treatment%20with%20nMitoQ%20prevents%20an%20endothelin%20receptor-A%20pathway%20cardiac%20phenotype%20observed%20in%20adult%20male%20offspring%20exposed%20to%20hypoxia%20in%20utero&amp;volume=325&amp;publication_year=2023&amp;pages=H136-H141&amp;pmid=37235521&amp;doi=10.1152/ajpheart.00238.2023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<span class="label">41.</span><cite>
Hula N, Spaans F, Vu J, Quon A, Kirschenman R, Cooke CLM, Phillips TJ, Case CP, Davidge ST. 2021. 
Placental treatment improves cardiac tolerance to ischemia/reperfusion insult in adult male and female offspring exposed to prenatal hypoxia. Pharmacol. Res.
165, 105461. ( 10.1016/j.phrs.2021.105461)
</cite> [<a href="https://doi.org/10.1016/j.phrs.2021.105461" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33513355/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol.%20Res.&amp;title=Placental%20treatment%20improves%20cardiac%20tolerance%20to%20ischemia/reperfusion%20insult%20in%20adult%20male%20and%20female%20offspring%20exposed%20to%20prenatal%20hypoxia&amp;volume=165&amp;publication_year=2021&amp;pages=105461&amp;pmid=33513355&amp;doi=10.1016/j.phrs.2021.105461&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<span class="label">42.</span><cite>
Graton ME, Spaans F, He R, Chatterjee P, Kirschenman R, Quon A, Phillips TJ, Case CP, Davidge ST. 2024. 
Sex-specific differences in the mechanisms for enhanced thromboxane A2-mediated vasoconstriction in adult offspring exposed to prenatal hypoxia. Biol. Sex Differ.
15, 52. ( 10.1186/s13293-024-00627-x)
</cite> [<a href="https://doi.org/10.1186/s13293-024-00627-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11188502/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38898532/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biol.%20Sex%20Differ.&amp;title=Sex-specific%20differences%20in%20the%20mechanisms%20for%20enhanced%20thromboxane%20A2-mediated%20vasoconstriction%20in%20adult%20offspring%20exposed%20to%20prenatal%20hypoxia&amp;volume=15&amp;publication_year=2024&amp;pages=52&amp;pmid=38898532&amp;doi=10.1186/s13293-024-00627-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43">
<span class="label">43.</span><cite>
Krause BJ, Paz AA, Garrud TAC, Peñaloza E, Vega-Tapia F, Ford SG, Niu Y, Giussani DA. 2024. 
Epigenetic regulation by hypoxia, N-acetylcysteine and hydrogen sulphide of the fetal vasculature in growth restricted offspring: a study in humans and chicken embryos. J. Physiol.
602, 3833–3852. ( 10.1113/JP286266)
</cite> [<a href="https://doi.org/10.1113/JP286266" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38985827/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Epigenetic%20regulation%20by%20hypoxia,%20N-acetylcysteine%20and%20hydrogen%20sulphide%20of%20the%20fetal%20vasculature%20in%20growth%20restricted%20offspring:%20a%20study%20in%20humans%20and%20chicken%20embryos&amp;volume=602&amp;publication_year=2024&amp;pages=3833-3852&amp;pmid=38985827&amp;doi=10.1113/JP286266&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44">
<span class="label">44.</span><cite>
Herrera EA, et al. 2017. 
N‐acetylcysteine, a glutathione precursor, reverts vascular dysfunction and endothelial epigenetic programming in intrauterine growth restricted guinea pigs. J. Physiol.
595, 1077–1092. ( 10.1113/jp273396)
</cite> [<a href="https://doi.org/10.1113/jp273396" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5309367/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27739590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=N%E2%80%90acetylcysteine,%20a%20glutathione%20precursor,%20reverts%20vascular%20dysfunction%20and%20endothelial%20epigenetic%20programming%20in%20intrauterine%20growth%20restricted%20guinea%20pigs&amp;volume=595&amp;publication_year=2017&amp;pages=1077-1092&amp;pmid=27739590&amp;doi=10.1113/jp273396&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45">
<span class="label">45.</span><cite>
Inocencio IM, Polglase GR, Nitsos I, Miller SL, Allison BJ. 2020. 
Maternal sildenafil impairs the cardiovascular adaptations to chronic hypoxaemia in fetal sheep. J. Physiol.
598, 4405–4419. ( 10.1113/jp279248)
</cite> [<a href="https://doi.org/10.1113/jp279248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7589206/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32754905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Maternal%20sildenafil%20impairs%20the%20cardiovascular%20adaptations%20to%20chronic%20hypoxaemia%20in%20fetal%20sheep&amp;volume=598&amp;publication_year=2020&amp;pages=4405-4419&amp;pmid=32754905&amp;doi=10.1113/jp279248&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46">
<span class="label">46.</span><cite>
Itani N, Skeffington KL, Beck C, Giussani DA. 2017. 
Sildenafil therapy for fetal cardiovascular dysfunction during hypoxic development: studies in the chick embryo. J. Physiol.
595, 1563–1573. ( 10.1113/jp273393)
</cite> [<a href="https://doi.org/10.1113/jp273393" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5330925/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27861916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Sildenafil%20therapy%20for%20fetal%20cardiovascular%20dysfunction%20during%20hypoxic%20development:%20studies%20in%20the%20chick%20embryo&amp;volume=595&amp;publication_year=2017&amp;pages=1563-1573&amp;pmid=27861916&amp;doi=10.1113/jp273393&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47">
<span class="label">47.</span><cite>
Inocencio IM, Polglase GR, Miller SL, Sehgal A, Sutherland A, Mihelakis J, Li A, Allison BJ. 2019. 
Effects of maternal sildenafil treatment on vascular function in growth-restricted fetal sheep. Arterioscler. Thromb. Vasc. Biol.
39, 731–740. ( 10.1161/atvbaha.119.312366)
</cite> [<a href="https://doi.org/10.1161/atvbaha.119.312366" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30841708/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arterioscler.%20Thromb.%20Vasc.%20Biol.&amp;title=Effects%20of%20maternal%20sildenafil%20treatment%20on%20vascular%20function%20in%20growth-restricted%20fetal%20sheep&amp;volume=39&amp;publication_year=2019&amp;pages=731-740&amp;pmid=30841708&amp;doi=10.1161/atvbaha.119.312366&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48">
<span class="label">48.</span><cite>
Liu Y, Un EMW, Bai Y, Chan MK, Zeng LX, Lei SL, Li J, Ung COL. 2024. 
Safety and efficacy of phosphodiesterase-5 (PDE-5) inhibitors in fetal growth restriction: a systematic literature review and meta-analysis. J. Pharm. Pharm. Sci.
27, 13206. ( 10.3389/jpps.2024.13206)
</cite> [<a href="https://doi.org/10.3389/jpps.2024.13206" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11357966/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39211421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pharm.%20Pharm.%20Sci.&amp;title=Safety%20and%20efficacy%20of%20phosphodiesterase-5%20(PDE-5)%20inhibitors%20in%20fetal%20growth%20restriction:%20a%20systematic%20literature%20review%20and%20meta-analysis&amp;volume=27&amp;publication_year=2024&amp;pages=13206&amp;pmid=39211421&amp;doi=10.3389/jpps.2024.13206&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49">
<span class="label">49.</span><cite>
Darby JRT, et al. 2023. 
Acute resveratrol exposure does not impact hemodynamics of the fetal sheep. Physiol. Rep.
11, e15749. ( 10.14814/phy2.15749)
</cite> [<a href="https://doi.org/10.14814/phy2.15749" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10277215/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37332034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physiol.%20Rep.&amp;title=Acute%20resveratrol%20exposure%20does%20not%20impact%20hemodynamics%20of%20the%20fetal%20sheep&amp;volume=11&amp;publication_year=2023&amp;pages=e15749&amp;pmid=37332034&amp;doi=10.14814/phy2.15749&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50">
<span class="label">50.</span><cite>
Bourque SL, Dolinsky VW, Dyck JRB, Davidge ST. 2012. 
Maternal resveratrol treatment during pregnancy improves adverse fetal outcomes in a rat model of severe hypoxia. Placenta
33, 449–452. ( 10.1016/j.placenta.2012.01.012)
</cite> [<a href="https://doi.org/10.1016/j.placenta.2012.01.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22321195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Placenta&amp;title=Maternal%20resveratrol%20treatment%20during%20pregnancy%20improves%20adverse%20fetal%20outcomes%20in%20a%20rat%20model%20of%20severe%20hypoxia&amp;volume=33&amp;publication_year=2012&amp;pages=449-452&amp;pmid=22321195&amp;doi=10.1016/j.placenta.2012.01.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51">
<span class="label">51.</span><cite>
Shah A, Reyes LM, Morton JS, Fung D, Schneider J, Davidge ST. 2016. 
Effect of resveratrol on metabolic and cardiovascular function in male and female adult offspring exposed to prenatal hypoxia and a high‐fat diet. J. Physiol.
594, 1465–1482. ( 10.1113/jp271133)
</cite> [<a href="https://doi.org/10.1113/jp271133" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4771791/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26467260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Effect%20of%20resveratrol%20on%20metabolic%20and%20cardiovascular%20function%20in%20male%20and%20female%20adult%20offspring%20exposed%20to%20prenatal%20hypoxia%20and%20a%20high%E2%80%90fat%20diet&amp;volume=594&amp;publication_year=2016&amp;pages=1465-1482&amp;pmid=26467260&amp;doi=10.1113/jp271133&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52">
<span class="label">52.</span><cite>
Mattern J, Gemmell A, Allen PE, Mathers KE, Regnault TRH, Stansfield BK. 2023. 
Oral pyrroloquinoline quinone (PQQ) during pregnancy increases cardiomyocyte endowment in spontaneous IUGR guinea pigs. J. Dev. Orig. Health Dis.
14, 321–324. ( 10.1017/s2040174423000053)
</cite> [<a href="https://doi.org/10.1017/s2040174423000053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10202840/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36861270/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Dev.%20Orig.%20Health%20Dis.&amp;title=Oral%20pyrroloquinoline%20quinone%20(PQQ)%20during%20pregnancy%20increases%20cardiomyocyte%20endowment%20in%20spontaneous%20IUGR%20guinea%20pigs&amp;volume=14&amp;publication_year=2023&amp;pages=321-324&amp;pmid=36861270&amp;doi=10.1017/s2040174423000053&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53">
<span class="label">53.</span><cite>
Kane AD, Herrera EA, Hansell JA, Giussani DA. 2012. 
Statin treatment depresses the fetal defence to acute hypoxia via increasing nitric oxide bioavailability. J. Physiol.
590, 323–334. ( 10.1113/jphysiol.2011.217968)
</cite> [<a href="https://doi.org/10.1113/jphysiol.2011.217968" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3285068/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22106179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Statin%20treatment%20depresses%20the%20fetal%20defence%20to%20acute%20hypoxia%20via%20increasing%20nitric%20oxide%20bioavailability&amp;volume=590&amp;publication_year=2012&amp;pages=323-334&amp;pmid=22106179&amp;doi=10.1113/jphysiol.2011.217968&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54">
<span class="label">54.</span><cite>
Itani N, Skeffington KL, Beck C, Niu Y, Katzilieris‐Petras G, Smith N, Giussani DA. 2020. 
Protective effects of pravastatin on the embryonic cardiovascular system during hypoxic development. FASEB J.
34, 16504–16515. ( 10.1096/fj.202001743r)
</cite> [<a href="https://doi.org/10.1096/fj.202001743r" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33094855/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20J.&amp;title=Protective%20effects%20of%20pravastatin%20on%20the%20embryonic%20cardiovascular%20system%20during%20hypoxic%20development&amp;volume=34&amp;publication_year=2020&amp;pages=16504-16515&amp;pmid=33094855&amp;doi=10.1096/fj.202001743r&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55">
<span class="label">55.</span><cite>
Fox KA, Longo M, Tamayo E, Kechichian T, Bytautiene E, Hankins GDV, Saade GR, Costantine MM. 2011. 
Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1–induced preeclampsia. Am. J. Obstet. Gynecol.
205, 366. ( 10.1016/j.ajog.2011.06.083)</cite> [<a href="https://doi.org/10.1016/j.ajog.2011.06.083" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22083058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Obstet.%20Gynecol.&amp;title=Effects%20of%20pravastatin%20on%20mediators%20of%20vascular%20function%20in%20a%20mouse%20model%20of%20soluble%20Fms-like%20tyrosine%20kinase-1%E2%80%93induced%20preeclampsia&amp;volume=205&amp;publication_year=2011&amp;pages=366&amp;pmid=22083058&amp;doi=10.1016/j.ajog.2011.06.083&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56">
<span class="label">56.</span><cite>
Kane AD, Herrera EA, Camm EJ, Giussani DA. 2013. 
Vitamin C prevents intrauterine programming of in vivo cardiovascular dysfunction in the rat. Circ. J.
77, 2604–2611. ( 10.1253/circj.cj-13-0311)
</cite> [<a href="https://doi.org/10.1253/circj.cj-13-0311" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23856654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20J.&amp;title=Vitamin%20C%20prevents%20intrauterine%20programming%20of%20in%20vivo%20cardiovascular%20dysfunction%20in%20the%20rat&amp;volume=77&amp;publication_year=2013&amp;pages=2604-2611&amp;pmid=23856654&amp;doi=10.1253/circj.cj-13-0311&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B57">
<span class="label">57.</span><cite>
Richter HG, et al. 2012. 
Ascorbate prevents placental oxidative stress and enhances birth weight in hypoxic pregnancy in rats. J. Physiol.
590, 1377–1387. ( 10.1113/jphysiol.2011.226340)
</cite> [<a href="https://doi.org/10.1113/jphysiol.2011.226340" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3382329/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22289909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Ascorbate%20prevents%20placental%20oxidative%20stress%20and%20enhances%20birth%20weight%20in%20hypoxic%20pregnancy%20in%20rats&amp;volume=590&amp;publication_year=2012&amp;pages=1377-1387&amp;pmid=22289909&amp;doi=10.1113/jphysiol.2011.226340&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B58">
<span class="label">58.</span><cite>
Brain KL, et al. 2019. 
Intervention against hypertension in the next generation programmed by developmental hypoxia. PLoS Biol.
17, e2006552. ( 10.1371/journal.pbio.2006552)
</cite> [<a href="https://doi.org/10.1371/journal.pbio.2006552" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6342530/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30668572/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Biol.&amp;title=Intervention%20against%20hypertension%20in%20the%20next%20generation%20programmed%20by%20developmental%20hypoxia&amp;volume=17&amp;publication_year=2019&amp;pages=e2006552&amp;pmid=30668572&amp;doi=10.1371/journal.pbio.2006552&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B59">
<span class="label">59.</span><cite>
Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH, Vitamins in Pre-eclampsia (VIP) Trial Consortium . 2006. 
Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet
367, 1145–1154. ( 10.1016/S0140-6736(06)68433-X)
</cite> [<a href="https://doi.org/10.1016/S0140-6736(06)68433-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16616557/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Vitamin%20C%20and%20vitamin%20E%20in%20pregnant%20women%20at%20risk%20for%20pre-eclampsia%20(VIP%20trial):%20randomised%20placebo-controlled%20trial&amp;volume=367&amp;publication_year=2006&amp;pages=1145-1154&amp;pmid=16616557&amp;doi=10.1016/S0140-6736(06)68433-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B60">
<span class="label">60.</span><cite>
Smith RAJ, Kelso GF, James AM, Murphy MP. 2004. 
Targeting coenzyme Q derivatives to mitochondria. Meth. Enzymol.
382, 45–67. ( 10.1016/S0076-6879(04)82003-2)</cite> [<a href="https://doi.org/10.1016/S0076-6879(04)82003-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15047095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Meth.%20Enzymol.&amp;title=Targeting%20coenzyme%20Q%20derivatives%20to%20mitochondria&amp;volume=382&amp;publication_year=2004&amp;pages=45-67&amp;pmid=15047095&amp;doi=10.1016/S0076-6879(04)82003-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B61">
<span class="label">61.</span><cite>
Smith RAJ, Murphy MP. 2010. 
Animal and human studies with the mitochondria‐targeted antioxidant MitoQ. Ann. N. Y. Acad. Sci.
1201, 96–103. ( 10.1111/j.1749-6632.2010.05627.x)
</cite> [<a href="https://doi.org/10.1111/j.1749-6632.2010.05627.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20649545/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20N.%20Y.%20Acad.%20Sci.&amp;title=Animal%20and%20human%20studies%20with%20the%20mitochondria%E2%80%90targeted%20antioxidant%20MitoQ&amp;volume=1201&amp;publication_year=2010&amp;pages=96-103&amp;pmid=20649545&amp;doi=10.1111/j.1749-6632.2010.05627.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B62">
<span class="label">62.</span><cite>
Asin-Cayuela J, Manas AR, James AM, Smith RA, Murphy MP. 2004. 
Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant. FEBS Lett.
571, 9–16. ( 10.1016/j.febslet.2004.06.045)
</cite> [<a href="https://doi.org/10.1016/j.febslet.2004.06.045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15280009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Lett.&amp;title=Fine-tuning%20the%20hydrophobicity%20of%20a%20mitochondria-targeted%20antioxidant&amp;volume=571&amp;publication_year=2004&amp;pages=9-16&amp;pmid=15280009&amp;doi=10.1016/j.febslet.2004.06.045&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B63">
<span class="label">63.</span><cite>
Williamson J, Hughes CM, Cobley JN, Davison GW. 2020. 
The mitochondria-targeted antioxidant MitoQ, attenuates exercise-induced mitochondrial DNA damage. Redox Biol.
36, 101673. ( 10.1016/j.redox.2020.101673)
</cite> [<a href="https://doi.org/10.1016/j.redox.2020.101673" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7452004/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32810739/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Redox%20Biol.&amp;title=The%20mitochondria-targeted%20antioxidant%20MitoQ,%20attenuates%20exercise-induced%20mitochondrial%20DNA%20damage&amp;volume=36&amp;publication_year=2020&amp;pages=101673&amp;pmid=32810739&amp;doi=10.1016/j.redox.2020.101673&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B64">
<span class="label">64.</span><cite>
Guzy RD, Schumacker PT. 2006. 
Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp. Physiol.
91, 807–819. ( 10.1113/expphysiol.2006.033506)
</cite> [<a href="https://doi.org/10.1113/expphysiol.2006.033506" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16857720/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp.%20Physiol.&amp;title=Oxygen%20sensing%20by%20mitochondria%20at%20complex%20III:%20the%20paradox%20of%20increased%20reactive%20oxygen%20species%20during%20hypoxia&amp;volume=91&amp;publication_year=2006&amp;pages=807-819&amp;pmid=16857720&amp;doi=10.1113/expphysiol.2006.033506&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B65">
<span class="label">65.</span><cite>
Xiao M, Zhong H, Xia L, Tao Y, Yin H. 2017. 
Pathophysiology of mitochondrial lipid oxidation: role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria. Free Radic. Biol. Med.
111, 316–327. ( 10.1016/j.freeradbiomed.2017.04.363)
</cite> [<a href="https://doi.org/10.1016/j.freeradbiomed.2017.04.363" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28456642/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Free%20Radic.%20Biol.%20Med.&amp;title=Pathophysiology%20of%20mitochondrial%20lipid%20oxidation:%20role%20of%204-hydroxynonenal%20(4-HNE)%20and%20other%20bioactive%20lipids%20in%20mitochondria&amp;volume=111&amp;publication_year=2017&amp;pages=316-327&amp;pmid=28456642&amp;doi=10.1016/j.freeradbiomed.2017.04.363&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B66">
<span class="label">66.</span><cite>
Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC, Smith RAJ, Murphy MP. 2001. 
Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidantand antiapoptotic properties. J. Biol. Chem.
276, 4588–4596. ( 10.1074/jbc.M009093200)
</cite> [<a href="https://doi.org/10.1074/jbc.M009093200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11092892/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Selective%20targeting%20of%20a%20redox-active%20ubiquinone%20to%20mitochondria%20within%20cells:%20antioxidantand%20antiapoptotic%20properties&amp;volume=276&amp;publication_year=2001&amp;pages=4588-4596&amp;pmid=11092892&amp;doi=10.1074/jbc.M009093200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B67">
<span class="label">67.</span><cite>
James AM, Cochemé HM, Smith RAJ, Murphy MP. 2005. 
Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J. Biol. Chem.
280, 21295–21312. ( 10.1074/jbc.M501527200)
</cite> [<a href="https://doi.org/10.1074/jbc.M501527200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15788391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Interactions%20of%20mitochondria-targeted%20and%20untargeted%20ubiquinones%20with%20the%20mitochondrial%20respiratory%20chain%20and%20reactive%20oxygen%20species.%20Implications%20for%20the%20use%20of%20exogenous%20ubiquinones%20as%20therapies%20and%20experimental%20tools&amp;volume=280&amp;publication_year=2005&amp;pages=21295-21312&amp;pmid=15788391&amp;doi=10.1074/jbc.M501527200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B68">
<span class="label">68.</span><cite>
Jackson TS, Xu A, Vita JA, Keaney JF Jr. 1998. 
Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ. Res.
83, 916–922. ( 10.1161/01.res.83.9.916)
</cite> [<a href="https://doi.org/10.1161/01.res.83.9.916" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9797340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Res.&amp;title=Ascorbate%20prevents%20the%20interaction%20of%20superoxide%20and%20nitric%20oxide%20only%20at%20very%20high%20physiological%20concentrations&amp;volume=83&amp;publication_year=1998&amp;pages=916-922&amp;pmid=9797340&amp;doi=10.1161/01.res.83.9.916&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B69">
<span class="label">69.</span><cite>
Massey LK, Liebman M, Kynast-Gales SA. 2005. 
Ascorbate increases human oxaluria and kidney stone risk. J. Nutr.
135, 1673–1677. ( 10.1093/jn/135.7.1673)
</cite> [<a href="https://doi.org/10.1093/jn/135.7.1673" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15987848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Nutr.&amp;title=Ascorbate%20increases%20human%20oxaluria%20and%20kidney%20stone%20risk&amp;volume=135&amp;publication_year=2005&amp;pages=1673-1677&amp;pmid=15987848&amp;doi=10.1093/jn/135.7.1673&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B70">
<span class="label">70.</span><cite>
Rumbold A, Duley L, Crowther CA, Haslam RR. 2008. 
Antioxidants for preventing pre-eclampsia. Cochrane Database Syst. Rev.
2008, CD004227. ( 10.1002/14651858.CD004227.pub3)
</cite> [<a href="https://doi.org/10.1002/14651858.CD004227.pub3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6718237/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18254042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cochrane%20Database%20Syst.%20Rev.&amp;title=Antioxidants%20for%20preventing%20pre-eclampsia&amp;volume=2008&amp;publication_year=2008&amp;pages=CD004227&amp;pmid=18254042&amp;doi=10.1002/14651858.CD004227.pub3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B71">
<span class="label">71.</span><cite>
Serón-Ferré M, et al. 2012. 
Circadian rhythms in the fetus. Mol. Cell. Endocrinol.
349, 68–75. ( 10.1016/j.mce.2011.07.039)
</cite> [<a href="https://doi.org/10.1016/j.mce.2011.07.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21840372/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell.%20Endocrinol.&amp;title=Circadian%20rhythms%20in%20the%20fetus&amp;volume=349&amp;publication_year=2012&amp;pages=68-75&amp;pmid=21840372&amp;doi=10.1016/j.mce.2011.07.039&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B72">
<span class="label">72.</span><cite>
Chen YC, Sheen JM, Tiao MM, Tain YL, Huang LT. 2013. 
Roles of melatonin in fetal programming in compromised pregnancies. Int. J. Mol. Sci.
14, 5380–5401. ( 10.3390/ijms14035380)
</cite> [<a href="https://doi.org/10.3390/ijms14035380" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3634509/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23466884/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Roles%20of%20melatonin%20in%20fetal%20programming%20in%20compromised%20pregnancies&amp;volume=14&amp;publication_year=2013&amp;pages=5380-5401&amp;pmid=23466884&amp;doi=10.3390/ijms14035380&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B73">
<span class="label">73.</span><cite>
Lemley CO, Meyer AM, Camacho LE, Neville TL, Newman DJ, Caton JS, Vonnahme KA. 2012. 
Melatonin supplementation alters uteroplacental hemodynamics and fetal development in an ovine model of intrauterine growth restriction. Am. J. Physiol. Regul. Integr. Comp. Physiol.
302, R454–R467. ( 10.1152/ajpregu.00407.2011)
</cite> [<a href="https://doi.org/10.1152/ajpregu.00407.2011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22129617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Physiol.%20Regul.%20Integr.%20Comp.%20Physiol.&amp;title=Melatonin%20supplementation%20alters%20uteroplacental%20hemodynamics%20and%20fetal%20development%20in%20an%20ovine%20model%20of%20intrauterine%20growth%20restriction&amp;volume=302&amp;publication_year=2012&amp;pages=R454-R467&amp;pmid=22129617&amp;doi=10.1152/ajpregu.00407.2011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B74">
<span class="label">74.</span><cite>
Richter HG, Hansell JA, Raut S, Giussani DA. 2009. 
Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy. J. Pineal Res.
46, 357–364. ( 10.1111/j.1600-079x.2009.00671.x)
</cite> [<a href="https://doi.org/10.1111/j.1600-079x.2009.00671.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19552758/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pineal%20Res.&amp;title=Melatonin%20improves%20placental%20efficiency%20and%20birth%20weight%20and%20increases%20the%20placental%20expression%20of%20antioxidant%20enzymes%20in%20undernourished%20pregnancy&amp;volume=46&amp;publication_year=2009&amp;pages=357-364&amp;pmid=19552758&amp;doi=10.1111/j.1600-079x.2009.00671.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B75">
<span class="label">75.</span><cite>
Tain YL, Huang LT, Hsu CN. 2017. 
Developmental programming of adult disease: reprogramming by melatonin?
Int. J. Mol. Sci.
18, 426. ( 10.3390/ijms18020426)
</cite> [<a href="https://doi.org/10.3390/ijms18020426" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5343960/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28212315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Developmental%20programming%20of%20adult%20disease:%20reprogramming%20by%20melatonin?&amp;volume=18&amp;publication_year=2017&amp;pages=426&amp;pmid=28212315&amp;doi=10.3390/ijms18020426&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B76">
<span class="label">76.</span><cite>
Tain YL, Huang LT, Hsu CN, Lee CT. 2014. 
Melatonin therapy prevents programmed hypertension and nitric oxide deficiency in offspring exposed to maternal caloric restriction. Oxid. Med. Cell. Longev.
2014, 1–21. ( 10.1155/2014/283180)</cite> [<a href="https://doi.org/10.1155/2014/283180" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4016897/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24864188/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oxid.%20Med.%20Cell.%20Longev.&amp;title=Melatonin%20therapy%20prevents%20programmed%20hypertension%20and%20nitric%20oxide%20deficiency%20in%20offspring%20exposed%20to%20maternal%20caloric%20restriction&amp;volume=2014&amp;publication_year=2014&amp;pages=1-21&amp;pmid=24864188&amp;doi=10.1155/2014/283180&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B77">
<span class="label">77.</span><cite>
Tare M, Parkington HC, Wallace EM, Sutherland AE, Lim R, Yawno T, Coleman HA, Jenkin G, Miller SL. 2014. 
Maternal melatonin administration mitigates coronary stiffness and endothelial dysfunction, and improves heart resilience to insult in growth restricted lambs. J. Physiol.
592, 2695–2709. ( 10.1113/jphysiol.2014.270934)
</cite> [<a href="https://doi.org/10.1113/jphysiol.2014.270934" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4080947/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24710061/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Maternal%20melatonin%20administration%20mitigates%20coronary%20stiffness%20and%20endothelial%20dysfunction,%20and%20improves%20heart%20resilience%20to%20insult%20in%20growth%20restricted%20lambs&amp;volume=592&amp;publication_year=2014&amp;pages=2695-2709&amp;pmid=24710061&amp;doi=10.1113/jphysiol.2014.270934&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B78">
<span class="label">78.</span><cite>
Andersen LPH, Gögenur I, Rosenberg J, Reiter RJ. 2016. 
The safety of melatonin in humans. Clin. Drug Investig.
36, 169–175. ( 10.1007/s40261-015-0368-5)</cite> [<a href="https://doi.org/10.1007/s40261-015-0368-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26692007/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Drug%20Investig.&amp;title=The%20safety%20of%20melatonin%20in%20humans&amp;volume=36&amp;publication_year=2016&amp;pages=169-175&amp;pmid=26692007&amp;doi=10.1007/s40261-015-0368-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B79">
<span class="label">79.</span><cite>
Berry CE, Hare JM. 2004. 
Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J. Physiol.
555, 589–606. ( 10.1113/jphysiol.2003.055913)
</cite> [<a href="https://doi.org/10.1113/jphysiol.2003.055913" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1664875/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14694147/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Xanthine%20oxidoreductase%20and%20cardiovascular%20disease:%20molecular%20mechanisms%20and%20pathophysiological%20implications&amp;volume=555&amp;publication_year=2004&amp;pages=589-606&amp;pmid=14694147&amp;doi=10.1113/jphysiol.2003.055913&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B80">
<span class="label">80.</span><cite>
Derks JB, et al. 2010. 
Allopurinol reduces oxidative stress in the ovine fetal cardiovascular system following repeated episodes of ischemia-reperfusion. Pediatr. Res.
68, 374–380. ( 10.1203/PDR.0b013e3181ef7780)
</cite> [<a href="https://doi.org/10.1203/PDR.0b013e3181ef7780" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20613682/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr.%20Res.&amp;title=Allopurinol%20reduces%20oxidative%20stress%20in%20the%20ovine%20fetal%20cardiovascular%20system%20following%20repeated%20episodes%20of%20ischemia-reperfusion&amp;volume=68&amp;publication_year=2010&amp;pages=374-380&amp;pmid=20613682&amp;doi=10.1203/PDR.0b013e3181ef7780&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B81">
<span class="label">81.</span><cite>
Klumper J, et al. 2018. 
Behavioral and neurodevelopmental outcome of children after maternal allopurinol administration during suspected fetal hypoxia: 5-year follow up of the ALLO-trial. PLoS ONE
13, e0201063. ( 10.1371/journal.pone.0201063)
</cite> [<a href="https://doi.org/10.1371/journal.pone.0201063" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6107129/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30138355/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Behavioral%20and%20neurodevelopmental%20outcome%20of%20children%20after%20maternal%20allopurinol%20administration%20during%20suspected%20fetal%20hypoxia:%205-year%20follow%20up%20of%20the%20ALLO-trial&amp;volume=13&amp;publication_year=2018&amp;pages=e0201063&amp;pmid=30138355&amp;doi=10.1371/journal.pone.0201063&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B82">
<span class="label">82.</span><cite>
Crouwel F, et al. 2024. 
Multicentre study and systematic review: allopurinol exposure during pregnancy. Aliment. Pharmacol. Ther.
60, 503–518. ( 10.1111/apt.18126)
</cite> [<a href="https://doi.org/10.1111/apt.18126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38984819/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aliment.%20Pharmacol.%20Ther.&amp;title=Multicentre%20study%20and%20systematic%20review:%20allopurinol%20exposure%20during%20pregnancy&amp;volume=60&amp;publication_year=2024&amp;pages=503-518&amp;pmid=38984819&amp;doi=10.1111/apt.18126&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B83">
<span class="label">83.</span><cite>
Simsek M, Opperman RCM, Mulder CJJ, Lambalk CB, de Boer NKH. 2018. 
The teratogenicity of allopurinol: a comprehensive review of animal and human studies. Reprod. Toxicol.
81, 180–187. ( 10.1016/j.reprotox.2018.08.012)
</cite> [<a href="https://doi.org/10.1016/j.reprotox.2018.08.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30125681/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Reprod.%20Toxicol.&amp;title=The%20teratogenicity%20of%20allopurinol:%20a%20comprehensive%20review%20of%20animal%20and%20human%20studies&amp;volume=81&amp;publication_year=2018&amp;pages=180-187&amp;pmid=30125681&amp;doi=10.1016/j.reprotox.2018.08.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B84">
<span class="label">84.</span><cite>
Herrera EA, Kane AD, Hansell JA, Thakor AS, Allison BJ, Niu Y, Giussani DA. 2012. 
A role for xanthine oxidase in the control of fetal cardiovascular function in late gestation sheep. J. Physiol.
590, 1825–1837. ( 10.1113/jphysiol.2011.224576)
</cite> [<a href="https://doi.org/10.1113/jphysiol.2011.224576" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3573306/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22331413/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=A%20role%20for%20xanthine%20oxidase%20in%20the%20control%20of%20fetal%20cardiovascular%20function%20in%20late%20gestation%20sheep&amp;volume=590&amp;publication_year=2012&amp;pages=1825-1837&amp;pmid=22331413&amp;doi=10.1113/jphysiol.2011.224576&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B85">
<span class="label">85.</span><cite>
Blum A, Shamburek R. 2009. 
The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis
203, 325–330. ( 10.1016/j.atherosclerosis.2008.08.022)
</cite> [<a href="https://doi.org/10.1016/j.atherosclerosis.2008.08.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18834985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=The%20pleiotropic%20effects%20of%20statins%20on%20endothelial%20function,%20vascular%20inflammation,%20immunomodulation%20and%20thrombogenesis&amp;volume=203&amp;publication_year=2009&amp;pages=325-330&amp;pmid=18834985&amp;doi=10.1016/j.atherosclerosis.2008.08.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B86">
<span class="label">86.</span><cite>
Poornima IG, Pulipati VP, Brinton EA, Wild RA. 2023. 
Update on statin use in pregnancy. Am. J. Med.
136, 12–14. ( 10.1016/j.amjmed.2022.08.029)
</cite> [<a href="https://doi.org/10.1016/j.amjmed.2022.08.029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10575572/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36150512/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Med.&amp;title=Update%20on%20statin%20use%20in%20pregnancy&amp;volume=136&amp;publication_year=2023&amp;pages=12-14&amp;pmid=36150512&amp;doi=10.1016/j.amjmed.2022.08.029&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B87">
<span class="label">87.</span><cite>
Tan L, et al. 2024. 
Statins prevent the deleterious consequences of placental chemerin upregulation in preeclampsia. Hypertension
81, 861–875. ( 10.1161/hypertensionaha.123.22457)
</cite> [<a href="https://doi.org/10.1161/hypertensionaha.123.22457" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10956680/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38361240/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Statins%20prevent%20the%20deleterious%20consequences%20of%20placental%20chemerin%20upregulation%20in%20preeclampsia&amp;volume=81&amp;publication_year=2024&amp;pages=861-875&amp;pmid=38361240&amp;doi=10.1161/hypertensionaha.123.22457&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B88">
<span class="label">88.</span><cite>
Ahmed A, et al. 2020. 
Pravastatin for early‐onset pre‐eclampsia: a randomised, blinded, placebo‐controlled trial. BJOG
127, 478–488. ( 10.1111/1471-0528.16013)
</cite> [<a href="https://doi.org/10.1111/1471-0528.16013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7063986/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31715077/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BJOG&amp;title=Pravastatin%20for%20early%E2%80%90onset%20pre%E2%80%90eclampsia:%20a%20randomised,%20blinded,%20placebo%E2%80%90controlled%20trial&amp;volume=127&amp;publication_year=2020&amp;pages=478-488&amp;pmid=31715077&amp;doi=10.1111/1471-0528.16013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B89">
<span class="label">89.</span><cite>
Döbert M, et al. 2021. 
Pravastatin versus placebo in pregnancies at high risk of term preeclampsia. Circulation
144, 670–679. ( 10.1161/circulationaha.121.053963)
</cite> [<a href="https://doi.org/10.1161/circulationaha.121.053963" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34162218/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Pravastatin%20versus%20placebo%20in%20pregnancies%20at%20high%20risk%20of%20term%20preeclampsia&amp;volume=144&amp;publication_year=2021&amp;pages=670-679&amp;pmid=34162218&amp;doi=10.1161/circulationaha.121.053963&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B90">
<span class="label">90.</span><cite>
Kovacic P, Somanathan R. 2010. 
Multifaceted approach to resveratrol bioactivity: focus on antioxidant action, cell signaling and safety. Oxidative Med. Cell. Longev.
3, 86–100. ( 10.4161/oxim.3.2.11147)</cite> [<a href="https://doi.org/10.4161/oxim.3.2.11147" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2952093/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20716933/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oxidative%20Med.%20Cell.%20Longev.&amp;title=Multifaceted%20approach%20to%20resveratrol%20bioactivity:%20focus%20on%20antioxidant%20action,%20cell%20signaling%20and%20safety&amp;volume=3&amp;publication_year=2010&amp;pages=86-100&amp;pmid=20716933&amp;doi=10.4161/oxim.3.2.11147&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B91">
<span class="label">91.</span><cite>
Darby JRT, et al. 2019. 
Subcutaneous maternal resveratrol treatment increases uterine artery blood flow in the pregnant ewe and increases fetal but not cardiac growth. J. Physiol.
597, 5063–5077. ( 10.1113/jp278110)
</cite> [<a href="https://doi.org/10.1113/jp278110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31483497/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Subcutaneous%20maternal%20resveratrol%20treatment%20increases%20uterine%20artery%20blood%20flow%20in%20the%20pregnant%20ewe%20and%20increases%20fetal%20but%20not%20cardiac%20growth&amp;volume=597&amp;publication_year=2019&amp;pages=5063-5077&amp;pmid=31483497&amp;doi=10.1113/jp278110&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B92">
<span class="label">92.</span><cite>
Darby JRT, Mohd Dollah MHB, Regnault TRH, Williams MT, Morrison JL. 2019. 
Systematic review: impact of resveratrol exposure during pregnancy on maternal and fetal outcomes in animal models of human pregnancy complications—are we ready for the clinic?
Pharmacol. Res.
144, 264–278. ( 10.1016/j.phrs.2019.04.020)
</cite> [<a href="https://doi.org/10.1016/j.phrs.2019.04.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31029765/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol.%20Res.&amp;title=Systematic%20review:%20impact%20of%20resveratrol%20exposure%20during%20pregnancy%20on%20maternal%20and%20fetal%20outcomes%20in%20animal%20models%20of%20human%20pregnancy%20complications%E2%80%94are%20we%20ready%20for%20the%20clinic?&amp;volume=144&amp;publication_year=2019&amp;pages=264-278&amp;pmid=31029765&amp;doi=10.1016/j.phrs.2019.04.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B93">
<span class="label">93.</span><cite>
Roberts VH, Pound LD, Thorn SR, Gillingham MB, Thornburg KL, Friedman JE, Frias AE, Grove KL. 2014. 
Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates. FASEB J.
28, 2466–2477. ( 10.1096/fj.13-245472)
</cite> [<a href="https://doi.org/10.1096/fj.13-245472" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4021444/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24563374/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20J.&amp;title=Beneficial%20and%20cautionary%20outcomes%20of%20resveratrol%20supplementation%20in%20pregnant%20nonhuman%20primates&amp;volume=28&amp;publication_year=2014&amp;pages=2466-2477&amp;pmid=24563374&amp;doi=10.1096/fj.13-245472&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B94">
<span class="label">94.</span><cite>
Ramli I, Posadino AM, Giordo R, Fenu G, Fardoun M, Iratni R, Eid AH, Zayed H, Pintus G. 2023. 
Effect of resveratrol on pregnancy, prenatal complications and pregnancy-associated structure alterations. Antioxidants
12, 341. ( 10.3390/antiox12020341)
</cite> [<a href="https://doi.org/10.3390/antiox12020341" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9952837/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36829900/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antioxidants&amp;title=Effect%20of%20resveratrol%20on%20pregnancy,%20prenatal%20complications%20and%20pregnancy-associated%20structure%20alterations&amp;volume=12&amp;publication_year=2023&amp;pages=341&amp;pmid=36829900&amp;doi=10.3390/antiox12020341&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B95">
<span class="label">95.</span><cite>
Aldini G, Altomare A, Baron G, Vistoli G, Carini M, Borsani L, Sergio F. 2018. 
N-acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why. Free Radic. Res.
52, 751–762. ( 10.1080/10715762.2018.1468564)
</cite> [<a href="https://doi.org/10.1080/10715762.2018.1468564" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29742938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Free%20Radic.%20Res.&amp;title=N-acetylcysteine%20as%20an%20antioxidant%20and%20disulphide%20breaking%20agent:%20the%20reasons%20why&amp;volume=52&amp;publication_year=2018&amp;pages=751-762&amp;pmid=29742938&amp;doi=10.1080/10715762.2018.1468564&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B96">
<span class="label">96.</span><cite>
Conde-Agudelo A, Romero R, Jung EJ, Garcia Sánchez ÁJ. 2020. 
Management of clinical chorioamnionitis: an evidence-based approach. Am. J. Obstet. Gynecol.
223, 848–869. ( 10.1016/j.ajog.2020.09.044)
</cite> [<a href="https://doi.org/10.1016/j.ajog.2020.09.044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8315154/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33007269/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Obstet.%20Gynecol.&amp;title=Management%20of%20clinical%20chorioamnionitis:%20an%20evidence-based%20approach&amp;volume=223&amp;publication_year=2020&amp;pages=848-869&amp;pmid=33007269&amp;doi=10.1016/j.ajog.2020.09.044&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B97">
<span class="label">97.</span><cite>
Shahin AY, Hassanin IMA, Ismail AM, Kruessel JS, Hirchenhain J. 2009. 
Effect of oral N-acetyl cysteine on recurrent preterm labor following treatment for bacterial vaginosis. Int. J. Gynaecol. Obstet.
104, 44–48. ( 10.1016/j.ijgo.2008.08.026)
</cite> [<a href="https://doi.org/10.1016/j.ijgo.2008.08.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18851855/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Gynaecol.%20Obstet.&amp;title=Effect%20of%20oral%20N-acetyl%20cysteine%20on%20recurrent%20preterm%20labor%20following%20treatment%20for%20bacterial%20vaginosis&amp;volume=104&amp;publication_year=2009&amp;pages=44-48&amp;pmid=18851855&amp;doi=10.1016/j.ijgo.2008.08.026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B98">
<span class="label">98.</span><cite>
Roes EM, Raijmakers MT, Boo TM de, Zusterzeel PL, Merkus HM, Peters WH, Steegers EA. 2006. 
Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol.
127, 61–67. ( 10.1016/j.ejogrb.2005.09.007)
</cite> [<a href="https://doi.org/10.1016/j.ejogrb.2005.09.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16243427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Obstet.%20Gynecol.%20Reprod.%20Biol.&amp;title=Oral%20N-acetylcysteine%20administration%20does%20not%20stabilise%20the%20process%20of%20established%20severe%20preeclampsia&amp;volume=127&amp;publication_year=2006&amp;pages=61-67&amp;pmid=16243427&amp;doi=10.1016/j.ejogrb.2005.09.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B99">
<span class="label">99.</span><cite>
Ezeriņa D, Takano Y, Hanaoka K, Urano Y, Dick TP. 2018. 
N-acetyl cysteine functions as a fast-acting antioxidant by triggering intracellular H2S and sulfane sulfur production. Cell Chem. Biol.
25, 447–459.( 10.1016/j.chembiol.2018.01.011)
</cite> [<a href="https://doi.org/10.1016/j.chembiol.2018.01.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6455997/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29429900/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Chem.%20Biol.&amp;title=N-acetyl%20cysteine%20functions%20as%20a%20fast-acting%20antioxidant%20by%20triggering%20intracellular%20H2S%20and%20sulfane%20sulfur%20production&amp;volume=25&amp;publication_year=2018&amp;pages=447-459&amp;pmid=29429900&amp;doi=10.1016/j.chembiol.2018.01.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B100">
<span class="label">100.</span><cite>
Pedre B, Barayeu U, Ezeriņa D, Dick TP. 2021. 
The mechanism of action of N-acetylcysteine (NAC): the emerging role of H2S and sulfane sulfur species. Pharmacol. Ther.
228, 107916. ( 10.1016/j.pharmthera.2021.107916)
</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2021.107916" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34171332/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol.%20Ther.&amp;title=The%20mechanism%20of%20action%20of%20N-acetylcysteine%20(NAC):%20the%20emerging%20role%20of%20H2S%20and%20sulfane%20sulfur%20species&amp;volume=228&amp;publication_year=2021&amp;pages=107916&amp;pmid=34171332&amp;doi=10.1016/j.pharmthera.2021.107916&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B101">
<span class="label">101.</span><cite>
Elbini Dhouib I, Jallouli M, Annabi A, Gharbi N, Elfazaa S, Lasram MM. 2016. 
A minireview on N-acetylcysteine: an old drug with new approaches. Life Sci.
151, 359–363. ( 10.1016/j.lfs.2016.03.003)
</cite> [<a href="https://doi.org/10.1016/j.lfs.2016.03.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26946308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Life%20Sci.&amp;title=A%20minireview%20on%20N-acetylcysteine:%20an%20old%20drug%20with%20new%20approaches&amp;volume=151&amp;publication_year=2016&amp;pages=359-363&amp;pmid=26946308&amp;doi=10.1016/j.lfs.2016.03.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B102">
<span class="label">102.</span><cite>
Yang G, Wang R. 2015. 
H2S and Blood Vessels: An Overview. In Chemistry, Biochemistry and Pharmacology of hydrogen sulfide. Handbook of experimental Pharmacology (eds Moore P, Whiteman M), pp. 85–110, vol. 230. Cham, Switzerland: Springer. ( 10.1007/978-3-319-18144-8_4)</cite> [<a href="https://doi.org/10.1007/978-3-319-18144-8_4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26162830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Chemistry,%20Biochemistry%20and%20Pharmacology%20of%20hydrogen%20sulfide.%20Handbook%20of%20experimental%20Pharmacology&amp;publication_year=2015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B103">
<span class="label">103.</span><cite>
Koupparis AJ, Jeremy JY, Muzaffar S, Persad R, Shukla N. 2005. 
Sildenafil inhibits the formation of superoxide and the expression of gp47 NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells. BJU Int.
96, 423–427. ( 10.1111/j.1464-410X.2005.05643.x)
</cite> [<a href="https://doi.org/10.1111/j.1464-410X.2005.05643.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16042742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BJU%20Int.&amp;title=Sildenafil%20inhibits%20the%20formation%20of%20superoxide%20and%20the%20expression%20of%20gp47%20NAD%5BP%5DH%20oxidase%20induced%20by%20the%20thromboxane%20A2%20mimetic,%20U46619,%20in%20corpus%20cavernosal%20smooth%20muscle%20cells&amp;volume=96&amp;publication_year=2005&amp;pages=423-427&amp;pmid=16042742&amp;doi=10.1111/j.1464-410X.2005.05643.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B104">
<span class="label">104.</span><cite>
Musicki B, Bivalacqua TJ, Champion HC, Burnett AL. 2014. 
Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis. J. Sex. Med.
11, 424–430. ( 10.1111/jsm.12391)
</cite> [<a href="https://doi.org/10.1111/jsm.12391" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4011711/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24251665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Sex.%20Med.&amp;title=Sildenafil%20promotes%20eNOS%20activation%20and%20inhibits%20NADPH%20oxidase%20in%20the%20transgenic%20sickle%20cell%20mouse%20penis&amp;volume=11&amp;publication_year=2014&amp;pages=424-430&amp;pmid=24251665&amp;doi=10.1111/jsm.12391&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B105">
<span class="label">105.</span><cite>
Francis SH, Corbin JD. 2003. 
Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonists. Curr. Urol. Rep.
4, 457–465. ( 10.1007/s11934-003-0027-x)
</cite> [<a href="https://doi.org/10.1007/s11934-003-0027-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14622499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Urol.%20Rep.&amp;title=Molecular%20mechanisms%20and%20pharmacokinetics%20of%20phosphodiesterase-5%20antagonists&amp;volume=4&amp;publication_year=2003&amp;pages=457-465&amp;pmid=14622499&amp;doi=10.1007/s11934-003-0027-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B106">
<span class="label">106.</span><cite>
von Dadelszen P, et al. 2011. 
Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG
118, 624–628. ( 10.1111/j.1471-0528.2010.02879.x)
</cite> [<a href="https://doi.org/10.1111/j.1471-0528.2010.02879.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21392225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BJOG&amp;title=Sildenafil%20citrate%20therapy%20for%20severe%20early-onset%20intrauterine%20growth%20restriction&amp;volume=118&amp;publication_year=2011&amp;pages=624-628&amp;pmid=21392225&amp;doi=10.1111/j.1471-0528.2010.02879.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B107">
<span class="label">107.</span><cite>
Dilworth MR, Andersson I, Renshall LJ, Cowley E, Baker P, Greenwood S, Sibley CP, Wareing M. 2013. 
Sildenafil citrate increases fetal weight in a mouse model of fetal growth restriction with a normal vascular phenotype. PLoS ONE
8, e77748. ( 10.1371/journal.pone.0077748)
</cite> [<a href="https://doi.org/10.1371/journal.pone.0077748" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3813774/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24204949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Sildenafil%20citrate%20increases%20fetal%20weight%20in%20a%20mouse%20model%20of%20fetal%20growth%20restriction%20with%20a%20normal%20vascular%20phenotype&amp;volume=8&amp;publication_year=2013&amp;pages=e77748&amp;pmid=24204949&amp;doi=10.1371/journal.pone.0077748&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B108">
<span class="label">108.</span><cite>
Satterfield MC, Bazer FW, Spencer TE, Wu G. 2010. 
Sildenafil citrate treatment enhances amino acid availability in the conceptus and fetal growth in an ovine model of intrauterine growth restriction. J. Nutr.
140, 251–258. ( 10.3945/jn.109.114678)
</cite> [<a href="https://doi.org/10.3945/jn.109.114678" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20018809/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Nutr.&amp;title=Sildenafil%20citrate%20treatment%20enhances%20amino%20acid%20availability%20in%20the%20conceptus%20and%20fetal%20growth%20in%20an%20ovine%20model%20of%20intrauterine%20growth%20restriction&amp;volume=140&amp;publication_year=2010&amp;pages=251-258&amp;pmid=20018809&amp;doi=10.3945/jn.109.114678&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B109">
<span class="label">109.</span><cite>
Stanley JL, Andersson IJ, Poudel R, Rueda-Clausen CF, Sibley CP, Davidge ST, Baker PN. 2012. 
Sildenafil citrate rescues fetal growth in the catechol-O-methyl transferase knockout mouse model. Hypertension
59, 1021–1028. ( 10.1161/HYPERTENSIONAHA.111.186270)
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.111.186270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22392899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Sildenafil%20citrate%20rescues%20fetal%20growth%20in%20the%20catechol-O-methyl%20transferase%20knockout%20mouse%20model&amp;volume=59&amp;publication_year=2012&amp;pages=1021-1028&amp;pmid=22392899&amp;doi=10.1161/HYPERTENSIONAHA.111.186270&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B110">
<span class="label">110.</span><cite>
Pels A, et al. 2020. 
Maternal sildenafil vs placebo in pregnant women with severe early-onset fetal growth restriction. JAMA Netw. Open
3, e205323. ( 10.1001/jamanetworkopen.2020.5323)
</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2020.5323" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7301225/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32585017/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Netw.%20Open&amp;title=Maternal%20sildenafil%20vs%20placebo%20in%20pregnant%20women%20with%20severe%20early-onset%20fetal%20growth%20restriction&amp;volume=3&amp;publication_year=2020&amp;pages=e205323&amp;pmid=32585017&amp;doi=10.1001/jamanetworkopen.2020.5323&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B111">
<span class="label">111.</span><cite>
Sharp A, et al. 2018. 
Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial. Lancet Child Adolesc. Health
2, 93–102. ( 10.1016/s2352-4642(17)30173-6)
</cite> [<a href="https://doi.org/10.1016/s2352-4642(17)30173-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30169244/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Child%20Adolesc.%20Health&amp;title=Maternal%20sildenafil%20for%20severe%20fetal%20growth%20restriction%20(STRIDER):%20a%20multicentre,%20randomised,%20placebo-controlled,%20double-blind%20trial&amp;volume=2&amp;publication_year=2018&amp;pages=93-102&amp;pmid=30169244&amp;doi=10.1016/s2352-4642(17)30173-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B112">
<span class="label">112.</span><cite>
Sharp A, Cornforth C, Alfirevic Z. 2019. 
Learning from the STRIDER trial. Obstet. Gynaecol. Reprod. Med.
29, 240–241. ( 10.1016/j.ogrm.2019.04.011)</cite> [<a href="https://doi.org/10.1016/j.ogrm.2019.04.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Obstet.%20Gynaecol.%20Reprod.%20Med.&amp;title=Learning%20from%20the%20STRIDER%20trial&amp;volume=29&amp;publication_year=2019&amp;pages=240-241&amp;doi=10.1016/j.ogrm.2019.04.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B113">
<span class="label">113.</span><cite>
Groom K, et al. 2019. 
STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early‐onset fetal growth restriction. BJOG
126, 997–1006. ( 10.1111/1471-0528.15658)
</cite> [<a href="https://doi.org/10.1111/1471-0528.15658" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30779295/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BJOG&amp;title=STRIDER%20NZAus:%20a%20multicentre%20randomised%20controlled%20trial%20of%20sildenafil%20therapy%20in%20early%E2%80%90onset%20fetal%20growth%20restriction&amp;volume=126&amp;publication_year=2019&amp;pages=997-1006&amp;pmid=30779295&amp;doi=10.1111/1471-0528.15658&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B114">
<span class="label">114.</span><cite>
Kubo M, et al. 2017. 
Safety and dose‐finding trial of tadalafil administered for fetal growth restriction: a phase‐1 clinical study. J. Obstet. Gynaecol. Res.
43, 1159–1168. ( 10.1111/jog.13345)
</cite> [<a href="https://doi.org/10.1111/jog.13345" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28718213/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Obstet.%20Gynaecol.%20Res.&amp;title=Safety%20and%20dose%E2%80%90finding%20trial%20of%20tadalafil%20administered%20for%20fetal%20growth%20restriction:%20a%20phase%E2%80%901%20clinical%20study&amp;volume=43&amp;publication_year=2017&amp;pages=1159-1168&amp;pmid=28718213&amp;doi=10.1111/jog.13345&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B115">
<span class="label">115.</span><cite>
Kubo M, Umekawa T, Maekawa Y, Tanaka H, Nii M, Murabayashi N, Osato K, Kamimoto Y, Ikeda T. 2017. 
Retrospective study of tadalafil for fetal growth restriction: impact on maternal and perinatal outcomes. J. Obstet. Gynaecol. Res.
43, 291–297. ( 10.1111/jog.13218)
</cite> [<a href="https://doi.org/10.1111/jog.13218" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27987345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Obstet.%20Gynaecol.%20Res.&amp;title=Retrospective%20study%20of%20tadalafil%20for%20fetal%20growth%20restriction:%20impact%20on%20maternal%20and%20perinatal%20outcomes&amp;volume=43&amp;publication_year=2017&amp;pages=291-297&amp;pmid=27987345&amp;doi=10.1111/jog.13218&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B116">
<span class="label">116.</span><cite>
Maki S, et al. 2019. 
Safety evaluation of tadalafil treatment for fetuses with early-onset growth restriction (TADAFER): results from the phase II trial. J. Clin. Med.
8, 856. ( 10.3390/jcm8060856)
</cite> [<a href="https://doi.org/10.3390/jcm8060856" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6617029/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31208060/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Med.&amp;title=Safety%20evaluation%20of%20tadalafil%20treatment%20for%20fetuses%20with%20early-onset%20growth%20restriction%20(TADAFER):%20results%20from%20the%20phase%20II%20trial&amp;volume=8&amp;publication_year=2019&amp;pages=856&amp;pmid=31208060&amp;doi=10.3390/jcm8060856&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B117">
<span class="label">117.</span><cite>
Balaban RS, Nemoto S, Finkel T. 2005. 
Mitochondria, oxidants, and aging. Cell
120, 483–495. ( 10.1016/j.cell.2005.02.001)
</cite> [<a href="https://doi.org/10.1016/j.cell.2005.02.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15734681/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Mitochondria,%20oxidants,%20and%20aging&amp;volume=120&amp;publication_year=2005&amp;pages=483-495&amp;pmid=15734681&amp;doi=10.1016/j.cell.2005.02.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B118">
<span class="label">118.</span><cite>
Clinical Trials . See
<a href="https://clinicaltrials.gov/search?term=mitoq&amp;aggFilters=status:&amp;viewType=Table" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://clinicaltrials.gov/search?term=mitoq&amp;aggFilters=status:&amp;viewType=Table</a> (accessed
9 July 2025).</cite>
</li>
<li id="B119">
<span class="label">119.</span><cite>
WHO . VigiAccess adverse event database (search terms: mitoq, mitoquinol mesylate, and mitoquinol mesylate from 2015-2025): no results were found for adverse events. See
<a href="https://www.vigiaccess.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.vigiaccess.org/</a> (accessed
2 July 2025).</cite>
</li>
<li id="B120">
<span class="label">120.</span><cite>
David AL. 2021. 
Ethical and regulatory considerations of placental therapeutics. Clin. Ther.
43, 297–307. ( 10.1016/j.clinthera.2021.01.003)</cite> [<a href="https://doi.org/10.1016/j.clinthera.2021.01.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33610291/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Ther.&amp;title=Ethical%20and%20regulatory%20considerations%20of%20placental%20therapeutics&amp;volume=43&amp;publication_year=2021&amp;pages=297-307&amp;pmid=33610291&amp;doi=10.1016/j.clinthera.2021.01.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B121">
<span class="label">121.</span><cite>
David AL, Ahmadzia H, Ashcroft R, Bucci-Rechtweg C, Spencer RN, Thornton S. 2022. 
Improving development of drug treatments for pregnant women and the fetus. Ther. Innov. Regul. Sci.
56, 976–990. ( 10.1007/s43441-022-00433-w)
</cite> [<a href="https://doi.org/10.1007/s43441-022-00433-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9315086/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35881237/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ther.%20Innov.%20Regul.%20Sci.&amp;title=Improving%20development%20of%20drug%20treatments%20for%20pregnant%20women%20and%20the%20fetus&amp;volume=56&amp;publication_year=2022&amp;pages=976-990&amp;pmid=35881237&amp;doi=10.1007/s43441-022-00433-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B122">
<span class="label">122.</span><cite>
Van Der Heijden JEM, Van Hove H, Van Elst NM, Van Den Broek P, Van Drongelen J, Scheepers HCJ, De Wildt SN, Greupink R. 2025. 
Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach. Am. J. Obstet. Gynecol.
232, 228. ( 10.1016/j.ajog.2024.05.012)</cite> [<a href="https://doi.org/10.1016/j.ajog.2024.05.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38763343/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Obstet.%20Gynecol.&amp;title=Optimization%20of%20the%20betamethasone%20and%20dexamethasone%20dosing%20regimen%20during%20pregnancy:%20a%20combined%20placenta%20perfusion%20and%20pregnancy%20physiologically%20based%20pharmacokinetic%20modeling%20approach&amp;volume=232&amp;publication_year=2025&amp;pages=228&amp;pmid=38763343&amp;doi=10.1016/j.ajog.2024.05.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B123">
<span class="label">123.</span><cite>
Swanson AM, David AL. 2015. 
Animal models of fetal growth restriction: considerations for translational medicine. Placenta
36, 623–630. ( 10.1016/j.placenta.2015.03.003)
</cite> [<a href="https://doi.org/10.1016/j.placenta.2015.03.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25819810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Placenta&amp;title=Animal%20models%20of%20fetal%20growth%20restriction:%20considerations%20for%20translational%20medicine&amp;volume=36&amp;publication_year=2015&amp;pages=623-630&amp;pmid=25819810&amp;doi=10.1016/j.placenta.2015.03.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B124">
<span class="label">124.</span><cite>
Morrison JL, et al. 2018. 
Guinea pig models for translation of the developmental origins of health and disease hypothesis into the clinic. J. Physiol.
596, 5535–5569. ( 10.1113/jp274948)
</cite> [<a href="https://doi.org/10.1113/jp274948" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6265540/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29633280/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Physiol.&amp;title=Guinea%20pig%20models%20for%20translation%20of%20the%20developmental%20origins%20of%20health%20and%20disease%20hypothesis%20into%20the%20clinic&amp;volume=596&amp;publication_year=2018&amp;pages=5535-5569&amp;pmid=29633280&amp;doi=10.1113/jp274948&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B125">
<span class="label">125.</span><cite>
Morrison JL, et al. 2018. 
Improving pregnancy outcomes in humans through studies in sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol.
315, R1123–R1153. ( 10.1152/ajpregu.00391.2017)
</cite> [<a href="https://doi.org/10.1152/ajpregu.00391.2017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30325659/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Physiol.%20Regul.%20Integr.%20Comp.%20Physiol.&amp;title=Improving%20pregnancy%20outcomes%20in%20humans%20through%20studies%20in%20sheep&amp;volume=315&amp;publication_year=2018&amp;pages=R1123-R1153&amp;pmid=30325659&amp;doi=10.1152/ajpregu.00391.2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B126">
<span class="label">126.</span><cite>
Barrow P. 2024. 
Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2022 and 2023. Reprod. Toxicol
130, 108727. ( 10.1016/j.reprotox.2024.108727)
</cite> [<a href="https://doi.org/10.1016/j.reprotox.2024.108727" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39332698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Reprod.%20Toxicol&amp;title=Review%20of%20embryo-fetal%20developmental%20toxicity%20studies%20performed%20for%20pharmaceuticals%20approved%20by%20FDA%20in%202022%20and%202023&amp;volume=130&amp;publication_year=2024&amp;pages=108727&amp;pmid=39332698&amp;doi=10.1016/j.reprotox.2024.108727&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B127">
<span class="label">127.</span><cite>
David AL, Spencer RN. 2022. 
Clinical assessment of fetal well‐being and fetal safety indicators. J. Clin. Pharmacol.
62, S67–S78. ( 10.1002/jcph.2126)
</cite> [<a href="https://doi.org/10.1002/jcph.2126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9544851/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36106777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Pharmacol.&amp;title=Clinical%20assessment%20of%20fetal%20well%E2%80%90being%20and%20fetal%20safety%20indicators&amp;volume=62&amp;publication_year=2022&amp;pages=S67-S78&amp;pmid=36106777&amp;doi=10.1002/jcph.2126&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B128">
<span class="label">128.</span><cite>
Musco H, Beecher K, Chand KK, Boyd RN, Colditz PB, Wixey JA. 2024. 
The search for blood biomarkers that indicate risk of adverse neurodevelopmental outcomes in fetal growth restriction. Front. Pediatr.
12, 1396102. ( 10.3389/fped.2024.1396102)
</cite> [<a href="https://doi.org/10.3389/fped.2024.1396102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11222567/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38966491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Pediatr.&amp;title=The%20search%20for%20blood%20biomarkers%20that%20indicate%20risk%20of%20adverse%20neurodevelopmental%20outcomes%20in%20fetal%20growth%20restriction&amp;volume=12&amp;publication_year=2024&amp;pages=1396102&amp;pmid=38966491&amp;doi=10.3389/fped.2024.1396102&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B129">
<span class="label">129.</span><cite>
Yakıştıran B, Katlan DC, Yüce T, Koç A. 2019. 
Neural and cardiac injury markers in fetal growth restriction and their relation to perinatal outcomes. Turk. J. Obstet. Gynecol.
16, 50–54. ( 10.4274/tjod.galenos.2019.84665)
</cite> [<a href="https://doi.org/10.4274/tjod.galenos.2019.84665" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6463424/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31019840/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Turk.%20J.%20Obstet.%20Gynecol.&amp;title=Neural%20and%20cardiac%20injury%20markers%20in%20fetal%20growth%20restriction%20and%20their%20relation%20to%20perinatal%20outcomes&amp;volume=16&amp;publication_year=2019&amp;pages=50-54&amp;pmid=31019840&amp;doi=10.4274/tjod.galenos.2019.84665&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B130">
<span class="label">130.</span><cite>
Mcdougall AR, Tuttle A, Goldstein M, Ammerdorffer A, Gülmezoglu AM, Vogel JP. 2022. 
Target product profiles for novel medicines to prevent and treat preeclampsia: an expert consensus. PLoS Glob. Public Health
2, e0001260. ( 10.1371/journal.pgph.0001260)
</cite> [<a href="https://doi.org/10.1371/journal.pgph.0001260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10021561/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36962694/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Glob.%20Public%20Health&amp;title=Target%20product%20profiles%20for%20novel%20medicines%20to%20prevent%20and%20treat%20preeclampsia:%20an%20expert%20consensus&amp;volume=2&amp;publication_year=2022&amp;pages=e0001260&amp;pmid=36962694&amp;doi=10.1371/journal.pgph.0001260&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B131">
<span class="label">131.</span><cite>
Spencer RN, et al. 2022. 
Development of standard definitions and grading for maternal and fetal adverse event terminology. Prenat. Diagn.
42, 15–26. ( 10.1002/pd.6047)
</cite> [<a href="https://doi.org/10.1002/pd.6047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34550624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prenat.%20Diagn.&amp;title=Development%20of%20standard%20definitions%20and%20grading%20for%20maternal%20and%20fetal%20adverse%20event%20terminology&amp;volume=42&amp;publication_year=2022&amp;pages=15-26&amp;pmid=34550624&amp;doi=10.1002/pd.6047&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B132">
<span class="label">132.</span><cite>
Sheppard M, Spencer RN, Ashcroft R, David AL. 2016. 
Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early‐onset fetal growth restriction. Ultrasound Obstet. Gynecol.
47, 484–491. ( 10.1002/uog.15880)
</cite> [<a href="https://doi.org/10.1002/uog.15880" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26968870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ultrasound%20Obstet.%20Gynecol.&amp;title=Ethics%20and%20social%20acceptability%20of%20a%20proposed%20clinical%20trial%20using%20maternal%20gene%20therapy%20to%20treat%20severe%20early%E2%80%90onset%20fetal%20growth%20restriction&amp;volume=47&amp;publication_year=2016&amp;pages=484-491&amp;pmid=26968870&amp;doi=10.1002/uog.15880&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B133">
<span class="label">133.</span><cite>
Spencer R, et al. 2019. 
Achieving orphan designation for placental insufficiency: annual incidence estimations in Europe. BJOG
126, 1157–1167. ( 10.1111/1471-0528.15590)
</cite> [<a href="https://doi.org/10.1111/1471-0528.15590" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30576053/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BJOG&amp;title=Achieving%20orphan%20designation%20for%20placental%20insufficiency:%20annual%20incidence%20estimations%20in%20Europe&amp;volume=126&amp;publication_year=2019&amp;pages=1157-1167&amp;pmid=30576053&amp;doi=10.1111/1471-0528.15590&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B134">
<span class="label">134.</span><cite>
Sertkaya A, Beleche T, Jessup A, Sommers BD. 2024. 
Costs of drug development and research and development intensity in the US, 2000-2018. JAMA Netw. Open
7, e2415445. ( 10.1001/jamanetworkopen.2024.15445)
</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2024.15445" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11214120/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38941099/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Netw.%20Open&amp;title=Costs%20of%20drug%20development%20and%20research%20and%20development%20intensity%20in%20the%20US,%202000-2018&amp;volume=7&amp;publication_year=2024&amp;pages=e2415445&amp;pmid=38941099&amp;doi=10.1001/jamanetworkopen.2024.15445&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All data presented in this review have been previously published and can be sourced from the following articles:</p>
<p>MitoQ; [<a href="#B36" class="usa-link" aria-describedby="B36">36</a>], vitamin C; [<a href="#B27" class="usa-link" aria-describedby="B27">27</a>], melatonin; [<a href="#B31" class="usa-link" aria-describedby="B31">31</a>], allopurinol; [<a href="#B28" class="usa-link" aria-describedby="B28">28</a>], pravastatin; [<a href="#B53" class="usa-link" aria-describedby="B53">53</a>].</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Philosophical Transactions of the Royal Society B: Biological Sciences are provided here courtesy of <strong>The Royal Society</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1098/rstb.2024.0183"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/rstb.2024.0183.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (4.2 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12368550/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12368550/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12368550%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12368550/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12368550/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12368550/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40836816/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12368550/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40836816/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12368550/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12368550/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="lsvo1N0PtKyqYQc8KEeTJKD38NmqytqLPPzsiC6NkRpIWVi5BYgWil2FuyBZxyDY">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
